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  Life is man’s most valuable possession and next one is health. Health is the 
seat Anchor of the ethical, economical, artistic and spiritual development of man. The 
wealth of a country depends on its Natural resources and the Vitality of its people. 
“GOD CREATED MAN IN HIS OWN IMAGE” 
  Man is the wonderful creation of god. The goal of life can be attained only by 
the harmonious development of sound mind in a sound body.  
 
SIDDHA SYSTEM OF MEDICINE  
        Siddha system is one of the antiquated and noble system of medicine. 
Siddhars  belived that the service to the humanity is the service to the lord. According 
to tradition it was lord shiva who unfolded the knowledge of Siddha System of 
Medicine to his concert Parvathi who handed this to Nandhi Deva and he handed to 
the Siddhars. 
  Siddha system of medical practice is considered as divine art as it lays its 
emphasis on inner soul in addition to that of external body. According to this system, 
man and nature are interlinked with each other. Any change in the nature or universe 
will influence the man. 
  Man is said to be the microcosm and universe is the macrocosm, which reveals 
what exists in the universe exists in the man. Man is a miniature of universe, 
containing five atoms of various principles, with constitutes minerals, vegetables & 
animal kingdom.   
  Siddhar’s the Scientist of Tamil culture, in their way to find the immortal life. 
This system of medicine is based on spiritualism; hence it is difficult to bring it into 
closer contact with modern methods. The principles underlying this system and the 
mechanism of this system works in still a myth 
  “Science without religion is lame 
  Religion without science is blind” 
               -Albert Einstein 
   “lVf<oke!Ou{<miuil<!big<jgg<G!nVf<kqbK!!
!nx<xK!Ohix<xq!B{qe<!
  -kqVg<Gxt<<< << <<!):53*!
  No medicine is necessary if we eat after assuring that what we have already 
eaten has been digested 
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 BASIC CONCEPTS AND PRINCIPELS OF SIDDHA 
  Our universe is created under the principle of five basic elements (so called 
Panchabootham), 96 Thathuvams, Sapdha Dathukal and three Humours Vatham, 
Pitham & Kapham.   The salient feature of this system is that which uproots the root 
cause of the disease and find perfect remedies for body, soul and mind.  Siddha 




  According to this human body is composed of the basic elements viz earth, 
water, fire, air and Ether. Human body is functioning on their homeostasis of three 
vital forces such as vadha, pitha and kaba. Any dearrangements in the homeostasis 
may lead to diseased condition called pini or noi. 
  “fqzl<!fQi<!kQ!utq!uqSl<Ohijmf<Kl<!
! gzf<k!lbg<gl<!dzglikzqe<”!
! ! ! ! ! .!okiz<gih<hqbl<!)269:*< < << < << < < !
! “uiklib<!hjmk<K!hqk<k!ue<eqbib<!gik<K!
! Osk<Kl!sQklib<!Kjmk<K”!
! ! ! ! ! .!Okjvbi<!lVk<K< << << < uh<!hivkl<< << << <!
! “lqgqEl<!GjxbqEl<!Ofib<!osb<Bl<!F~Ozii<!
! utq!Lkzi!w{<{qb!&e<X”!
! ! ! ! ! .!kqVg<Gxt<!):52*!lVf<K!nkqgivl<< < < << < < << < < <!
  The three vital forces circulating in the body in different proportions helps in 
the digestion of food and maintain the vitality of the body. When there is provocation 
in the ratio of vital forces it will be disturbing  the normal  condition and will result in 
dryness (vatham), heat(pitham) and cold  (kabam).  
  Kuzhanthai  maruthuvam  is   a specialized  branch  in  siddha  medicine   
which  deals with  the  treatment  of  the  diseases  of  children  upto  12 years. 
According, the lifetime  of children is divided into various stages or paruvams. Since 
they are kappu, senkkeerai, thalattu, sappani, mutham, varugai, ambuli, sitril, siruparai 
and sirutherviduthal paruvams. For female child they can further divided into 




           The disease that occurs in children can be broadly divided into two viz, karuvil 
thondrum noigal or Ahakaarana noigal, diseases that occur during the intrauterine 
period . Purakaarana noigal, the Disease that occur after the birth of child i.e due to 
extrinsic causes.  
  Siddhars  have   classified  the  disease  into  4448   types. Out of these 4448 
disease the author selected ‘Mannun veluppu Noi’. 
            ‘There is no cause which merits a higher priority than the protection and  
development of children, on whom the survival, stability and advancement  of all 
nations and indeed human civilization depends’ (plan of Action of the World Summit 
for Children, 1990). 
  One of the main aim of child survival and safe Motherhood programme 
(CSSM) is to eradicate childhood anaemia, since anaemia is the  most common 
disease  in the Indian context.   
         The major health concern in this modern world is due to life style modification 
and poor dietary style which is turn lead to many malnutritional diseases including 
anaemia. Anaemia usually results from either loss of blood by bleeding or an 
inadequate diet or malabsorption there are three main deficiencies that cause anaemia- 
Iron, vitamin B12 and folic acid. Iron deficiency anaemia is one of the most 
widespread disease all over the world, as it constitutes 90-95% of the total.  
  The prevalence of anaemia is highest in Women of reproductive age and 
children. Basically healthy nation, which depends mainly health of women and 
children. So my ultimate aim is to improve the health of the children. Keeping this 
aim in my mind. I have gone through various siddha literature to find a suitable, cost 
effective, safety haematinic for people, And I have decided to take SIRU VILVATHI 
ELAGAM mentioned in ANUBOGA VAITHIYA  NAVANEETHAM for the 
treatment of MANNUN VELUPPU NOI (Iron deficiency anaemia).  
  So the author has selected MANNUN VELUPPU  NOI (Iron deficiency 
anaemia)  for this dissertation work. In order to treat this, a safest highly efficacy and 
effective drug is needed so the author selected   SIRU VILVATHI ELAGAM  
  SIRU VILVATHI ELAGAM is a multi compound herbal drug  has the trial 
run through a literature review of modern and Siddha texts, Bio-Chemical, 
Pharmacological and clinical trial where carried out  and  the result obtained were 




2. AIM AND OBJECTIVE 
AIM:  
            Prevention and cure are basic aims in Siddha system of medicine, which 
prevent disease by careful dieting and proper relaxation of the mind to achieve a 
totality of health. 
 India being densely populated with people of different socio-economic status, 
children with poor sanitary facilities, poor, personal and environmental hygiene are 
the common victims of this disease. It forms one of the major causes of sickness 
among children which causes a heavy economic burden to health services. They have 
been suffering from various diseases due to deficiency on nutrition. 
 It is essential to find out a simple drug to treat this disease.  The drug should 
be easily available, economic, easily administered and also highly effective in smaller 
doses. 
 As a siddha pediatrician, an extra personal interest in the study of new drug for 
this common nutritional deficiency has been aimed.  
           The aim of the dissertation work is to analyse the selected disease Mannun 
Veluppu Noi (Iron deficiency anaemia). Both clinically and experimentally with the 
trial drug of SIRU VILVATHI ELAGAM 
 
OBJECTIVES 
1. To collect the literature of both siddha and modern aspects of the disease 
Mannun Veluppu Noi (IRON DEFICIENCY ANAEMIA).  
2. To study the clinical course of the disease with observation on the etiology, 
classification, pathology, prognosis, complications and treatment by siddha 
aspect. 
3. To have an idea about the incidence of the disease with age, occupation, 
economical status and climate conditions.  
4. To expose the clinical diagnostic methods mentioned by siddhars to know how 
the disease manifest due to deranged mukkutram, poripulangal, udal 
thathukkal e.t.c.   
5. To analyse the trial medicine in bio-chemically, pharmacologically and 




6. To make use of modern parameters in the investigation side to confirm the 
diagnosis and to follow the progress of patients. 
7. To have a clinical trial on the disease MANNUN VELUPPU NOI with the 
siddha drug SIRU VILVATHI ELAGAM. 












3. REVIEW OF LITERATURE 
SIDDHA ASPECT 
l{<[e<!ouTh<H< < << < << < < !Ofib<<<<!
Le<Ejv;<<< !
!!!!! dml<hqx<G! uzqjljbBl<! dvk<jkBl<! ogiMh<hK! kqvu! kqSuig!
-Vg<g%cb! GVkq,! -g<GVkqbieK! sh<kkiKg<gtqz<! -v{<miuK! kiKuig!
gVkh<hMgqxK/!
!!!!!dml<hqz<! dt<t! uqzr<gt<! )cells)! dbqi<! uip<ukx<G! sIg<gjvBl<, 
dbqIuiBUl<! lqgUl<! nusqblieK/! -u<uqv{<Ml<! ds<sq! Lkz<! dt<tr<giz<!
ujv! -Vg<g%cbK/! dml<hqz<! dt<t! nk<kje! uqzr<gTg<Gl<! OlZl<! sqvsqz<!
dt<t! Lg<gqblie! dXh<Hgtigqb! &jt! Ohie<xux<Xg<Gl<! dbqI,d{IU!
hqvi{uiB! Ohie<xjugjt! ntqg<gg<%cb! ujgbqz<! Olx<gi[l<!njek<jkBl<!
wMk<K!osz<zg<%cb!Lg<gqblie!Ye<xig!GVkq!gVkh<hMgqxK/!
!!!!!weOu! WOkEl<! yV! giv{l<! hx<xq! GVkq! uqzr<gt<! OgmjmBl<! ohiPK!
hi{<M! OfibieK! uVgqxK/! weOu! -ju! Gpf<jkgtqz<! d{<migqx! ohiPK!
Gpf<jkg<G! Ofib<k<kig<gl<! d{<migqxK/! weOu! Gpf<jkg<G! d{<miGl<!
l{<[e<!ouTh<H!Ofib<!lqgLg<gqbk<Kul<!uib<f<kkig!!gVkh<hMgqxK/!!
!!!!!Gpf<jkg<G! d{<miGl<! hi{<M! ! Ofib<! hz<OuX! giv{r<gtiz<!
d{<miGl<! nux<xqz<! l{<! d{<hkiz<! Gpf<jkg<G! d{<miGl<! hi{<M! Ofib<!
hx<xq!-g<gm<Mjvbqz<!uquvlig!%xh<hm<Mt<tK/!!!!!!!!
!! ouTh<H! OfibieK! Gpf<jkgtqml<! nkqgtuqz<! gi{h<hMl<! OfibiGl</!
utVl<! Gpf<jkgtqml<! -f<Ofib<! gi{h<hMukiz<?! -K! nuIgtqe<!
utIs<sqjbBl<?! gx<xz<! kqxjeBl<! ouGuig! hikqg<gqxK/! nkqZl<! ouTh<hqe<!
ujggtqz<! ye<xie! l{<[e<! ouTh<H! Ofib<! hz! kQb! uqjtUgjt!
Wx<hMk<KgqxK/! l{<?! sil<hz<! Ohie<x! ohiVm<gjt! d{<hkx<Gl<?! ouTh<H!
Ofib<g<Gl<! dt<t! okimIH! hx<xq! hz! sqk<kIgt<! ng<gizk<kqOzOb! fe<G! nxqf<K!
wPkq! juk<Kt<teI/! l{<?! sil<hz<! Ohie<xux<jx! sih<hqMuK! ouTh<H! Ofibqe<!
nxqGxqbigOui! nz<zK! -h<hpg<gOl! ouTh<H! Ofib<! Okix<Xuqg<g!
giv{ligOui!-Vg<gqxK/!!!
! sqX! ! Gpf<jkgTl<?! ! sqX! ! ubkqeVl<?! ! gVUx<x! ! oh{<gTl<?! ! l{<!
sil<hz<?!osr<gz<?!kqVfQX?!gx<h,vl<!-ux<xqe<!lQK!keqk<k!-s<js!ogi{<M!ntU!
gmf<K! d{<hkiz<! gi[l<! OfibiGl</! dm<ogi{<m! ohiVTg<G! Wx<h! ubqX!
Dkz<?! osiqbijl?! uif<kq?! gpqs<sz<?! Svl<?! ubqx<Xh<HP! Lkzqb! Ofib<gt<! g{<M!




OuXohbi<gt<!;!< << << < !
! ouTh<H!Ofib<?!ou{<jl!Ofib<?!ou{<hi{<ml</!!
-bz<!;<<< !
!!!!!“Okgk<kqe<! -vk<kk<kqz<! dt<t! squf<k! n[g<gt<! Gjxf<K! Okgl<!
ouTk<K!uqMukx<G!hi{<M!Ofib<<< <”!we<X!ohbi</!
!! npz<!Gx<xl<!lqGf<K!hqk<kk<kqe<!ujggtie!nex<hqk<kl<!lx<Xl<!-vR<sg!
hqk<kl<! -ux<jx! Ogmjmb! osb<K! GVkqbqe<! fqxk<jkBl<! wjmjbBl<! ogMk<K!
dmZg<G!Ou{<cb!Dm<mk<jkBl<!ogimilz<!dmjz!ouTg<gs<!osb<Bl<!Ofib<!
we<X!ngk<kqbi<!juk<kqb!hqt<jtk<!klqp<!< < < < < << < < < < << < < < < < we<El<!F~zqz<!%xh<hm<Mt<tK/!
!! OlZl<! hz<OuX! F~x<g<gt<! hi{<M! Ofibqe<! -bzig! hz<OuX! %x<Xg<gjt!
okiquqg<gqe<xK! nux<Xt<! Ofib<fimz<! Ofib<! Lkz<! fimz<! hGkq!< < < < << < < < << < < < < .3! we<El<!
Fizqz<!
!!!!!-bx<jg! fqxl<! lixq! dmz<! ouTk<K?! g{<?! fgg<g{<! -jugjt! fQg<gqh<!
hii<g<gqz<!GVkqbqe<xq!ouTk<kqVg<Gl<!OfibiGl<!we<X!%XgqxK/!
!
Ofib<!uVl<!upq<;< < << < << < < !
!!!!! hi{<M! Ofib<! uVl<! upq! hx<xq! hqe<uVl<! F~z<gtqz<! %xh<hm<Mt<tK,!!





!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!lV/ohie<!GV!sqOvie<l{q< << << < !
lkjz!Ofib<!lVk<Ku< << << < l<!we<x!F~< << << < zqe<!%x<Xhc< << << < ,!





                                                                            !


















! ! ! ! ! ! ! !!
 ohx<Oxiiqe<!lejk!OfiGl<!hc!osb<jg!osb<kz<!!
 ke<jeh<Ohiz<! dt<t! hqxqokiVuiqmLl<! ne<H! hivim<milz<! ouXh<jh!
gi{<hqkk<z<!
 giKhm! Ogm<guqbzik! nkqg! Suisk<jk! Wx<hMk<kg<! %cb! ujgbqz<!
Nr<givLl<!OgihLl<!ogit<tz<!
!!!!! Ngqb! -g<giv{r<gtiz<! hqk<kl<! nkqgh<hm<M! ! dml<hqz<! ouh<H! lqR<sq!
jggiz<gtqz<!!Osii<U!d{<miGl</!






!!! -f<OfibieK! lQe<Lt<?! dlq?! ofz<zqe<! gil<H?! we<H?! gz<?! oh{<gt<!








!!! lqGkqbig! ! d{U! ! ogit<ukiZl<?! nkqglig! ! fQi<! Gck<kziZl<?!
kivitlib<! ! fQm<ch<! hMg<gilz<! Lmg<gq! ogi{<M! hMk<Kg<! gqmh<hkiZl<!!
OlMht<tk<kqz<! hMk<Kg<! gqmh<hkiZl<?! oh{<Osi<g<jg! lqGkqbiZl<! ! -f<Ofib<!
hqxg<Gl</!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.w^</hq/-vilsf<kqve</< < << < << < < !
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Gpf<jk!Ofib<gt<!< < << < << < < we<x!F<<< ~zqe<!%x<Xhc< << << < ;!
!! dmzqz<! -vk<k! uqVk<kqg<Gk<! Okjubie! sQukiKg<gjtBjmb! d{Ug<!
GjxuqeiZl<! GVkqbqZt<t! osf<fqx! sQu! n[g<gt<! GjxuqeiZl<! -f<Ofib<!
Wx<hMl</!
.!lV/w^</sqkl<hvki[h<hqt<jt< < < << < < << < < < !)higl<!<<< I) 
!






















 lgihivkk<kqz<! Ks<sikee<! sqiqk<kK! Ohiz! -f<k! fim<cZt<t!
Ks<sikei<gt<! ohiqbui<gt<! lx<Xl<! fz<zui<gtqe<! osb<jgjbg<!
Gxqk<K!wt<tq!fjgbiceiz<!-KOhiz!Ofib<gt<!uf<K!OsVl</!!























 kqiqOkimr<gt<! Ogitixjmf<K! hi{<M! Ofib<! d{<miGl<! we!
%xh<hm<Mt<tK/!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !.lV/s/our<gm<mvi\e</< < << < << < < !
sqk<k!lVk<Kul<!ohiK< < << < << < < !we<x!F~zqe<!< << << < %x<Xhc;<<< !
 GVkqbqe<! ue<jljbg<! Gjxg<gg<! %cb! dh<H! Htqh<Ht<t!
ohiVt<gjt!lqGkqbig!ogit<ukiZl</!!
 Svl<?!Ohkq?!uif<kq?!gQz<uiB?!Lkzqb!Ofib<gTg<Gm<hMkziZl</!!!!!!!!!!!
 GVkqjb! ntU! gmf<K! outqbig<Gl<! GVkqg<gpqs<sz<?! GVkquif<kq!
Lkzqbju!Wx<hMkziZl<!
 oum<Mh<hm<M! lqGkqbigg<! GVkq! outqh<hMkziZl<! -f<Ofib<!
d{<miGl</!
 fs<Sk<ke<jlBjmb! lVf<Kgjt! fit<! ntUg<G! lqR<sq! d{<hkiZl<?!
dmjz! -jtg<gs<osb<Bl<! ubqx<Xh<HP! Ofib<?! -jth<H! Ofib<?! fq{g<!
gpqs<sz<! LkzqbjugtiZl<! GVkqh<! ohVg<jgg<! ogMg<gg<%cb! =vz<!
Ofib<gtiZl<?! Hjgbqjz?! oux<xqjzh<! hig<G?! l{<?! sil<hz?<! kqVfQX?!
gx<h,vl<!Lkzqbjugjt!ncg<gc!ogit<ukiZl<!-f<Ofib<!uVl</!
.!lV/g/fi/Gh<Hsilq!LkzqbiI<<< /!













svOhf<kqvi<!hi< << << < {<M!gilijz!Ovig!sqgqs<js!we<x!F~zqe<!< < < << < < << < < < %x<Xhc;<<< !
 Htqh<H?! dh<H! hkii<k<kr<gjtBl<?! giv! hkii<k<kr<gjtBl<! nkqgligh<!
Hsqk<kz<!!
 l{<sih<hqMkz<?! sih<hqm<mUme<! hgzqz<! nkqglig! dxr<gz<?!
Okgh<hbqx<sq?! -jugtqeiz<! siQvk<kqz<! hqk<kl<! Lkzqb! Okimr<gt<!
hqvOgihl<! njmf<K! -vk<kk<jkg<! ogMk<Ks<! siQvk<jk! ouTh<hig!
osb<gqe<x!Ofib<!we!%xh<hm<Mt<tK/!!
!!!!!!!!!!!!!!!!!!!!!!!! ! ! !.!lV/s/our<gm<mvi\e</< < << < << < < !
klqp<< <<!ngvikq<!we<x!F~zqe<!< < << < << < < %x<Xhc;<<< !
 sqz<oze<X! uQSl<! GtqVl<! gix<xqz<! kqiqukiZl<?! dm<gii<f<K! nz<zK!
hMk<kqVf<kiZl<?!!
 G{<cg<gib<! Ofib<?! FjvbQvz<?! l{<{Qvz<! Lkzqb! dXh<Hgjt!
kig<Gl<!Ofib<!OgitiXgtiZl<!!
 ne<xqBl<!-f<Ofib<!hqxuq!OfibiBl<!-Vg<gzil<!we!%xh<hm<Mt<tK/!!
!! ! ! ! ! ! ! !.!T.V/sil<hsqul<hqt<jt/< < << < << < < !
hi{<MOfib<!Lx<GxqG{r<gt< < < << < < << < < < <!;!
!! nkqglie! dmz<! Osii<U?! &s<S! uqm! sqvll<?! g{<! hii<ju! ytq! Ge<xz<?!
lbg<gl<?!lii<H!hmhmh<H?!dmz<!uzq<!d{<miGl</!
Gpf<jk!Ofib<gt<!< < << < << < < )higl<!<<< I*!
!!!!!!dmz<! fzqf<K! ueh<H?! ue<jl?! fqxl?<! ytq?! Ge<xz<?! sVl! ouch<H?!
SvSvh<Hme<! lbqVl<! dkqvz<?! l{<! sil<hz<! hiIg<jgbqz<! uqVh<hl?<! d{uqz<!
ouXh<H?! lzfQI! lR<stqk<kz<?! ohV&s<S?! gikqjvs<sz<?! lbg<gl<?! nskq?! liIH!
Kch<H?! fic! olzqU?! hsqbqe<jl?! -Mh<H! gMh<H! gi[l<?! -vk<kh<! hjsbqe<xq!
Lgl<?!uib<?!g{<?!fiU?!=X?!Lkzqb!ouTk<K!uQr<Gl</!!




ohiKg<GxqG{r<gt<!;!< < << < << < < !








!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.lV/!ohie</!GVsqOvi{<l{q< << << < !
!!!!!!hizuigmk<kqe<! %x<Xh<hc?! g{<! ouTk<kz<?! dmz<! uxm<sq?! dmx<Osii<U?!
uQg<gl<!d{<miGl</!!




!!!!!!Gpf<jk! l{<! nVf<kqeiz<! lzg<gm<M?! ncubqX! uQr<Gkz<?! dmz<!
ouTk<kz<!Wx<hMl</!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
ke<uf<kqiq!juk<kqbl<;< < < << < < << < < < !!




!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.lV/s/our<gm<mvi< << << < \e</<<< !
!! hsqbqe<jl?! lii<H! uzq?! sqXfQi<! fqxl<! lix<xl<?! g[g<giz<! uQg<gl<?! g{<!
-jl!uQr<gz<?!dmz<!ouTk<kz<!d{<miGl</!
!







!!!!!!!!!!!!!!!!!!!!!!!!!!!! ! ! .!Ou/-vi/likue</!
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hvvisOsgv!juk<kqbg<< << << <!jgObM;!
!!!!! Kvh<H?! -jth<H?! SuisLm<M?! -vk<kl<! ogm<M! OsiIU{<miGl<?!
-f<kqiqbr<gt<! OsiVl<?! nsel<! Ou{<miK! )d{uqz<! uqVh<hqviK*?! dm<Svl<?!
-jvh<H?! Okgl<! outqVl<?! fisqbqx<! stqB{<miGl<?! gikqjvg<Gl<?! kjzSx<X?!
dOvill<! dkqVl<?! Okgl<! geg<Gl<?! Lgl<! uQr<Gl<?! dkvk<kQ! lf<kliGl<?!
stqobiPGl<?! sqeg<Gl<?! ofR<SKcg<Gl<?! Hk<kq! lf<kliGl<?! kiK! ogMl<?!
GtqIs<sqjb!uqVl<hiK/!
.!lV/Os/squs{<Lgvi\i<<< !
















!!!!!KVk<kqfgi<!sk<klK< < << < << < < !Ogm<Gl<!hiOv”!
! ! ! !!!!!!!!!!!!!!!!!!!!!!.!ngk<kqbi<!G{< << << < uigml<<<<!
! ngk<kqbi<! G{uigmk<kqe<! %x<Xh<hc! Okiz<! uxm<sq?! Lgl<?! g{<?! fig<G?!
fgg<g{<! Lkzqbe! ouTk<kz<?! dmz<Osii<U?! ficfjmGjxU?! hsqbqe<jl?! g{<!
-jl!uQr<gz<?!&s<S!uir<gz<?!lii<H!hmhmh<H?!g[g<giz<!uQr<gz<!d{<miGl</!
!! KVkkqfgi<!sk<klK!fuQe!lVk<Kuk<kqz<!Haemic Murmur-J!yk<Kt<tK/!
nEOhig!juk<kqb!Oku!vgsqbl<;!< << << < !
 nkqgtU! l{<j{! d{<hkiz<! -vskiK! lx<Xl<! -vk<kkiK!
olzqujmf<K!ouTh<H!Ofib<!d{<miGl</!
 nkeiz<! lzg<gm<M?! lzk<kqz<HPg<gt<! gi{z<?! okih<Ht<?! Lgl<?! giz<?!
-edXh<Hgtqz<!uQg<gl<!Wx<hmz</!!



















!! hkqo{e<! sqk<ki<gt<! fic! si^<kqvl<! we<El<! F~z<! %x<Xh<hc?! -Vlz<?!
-jth<H?! ofR<Suzq?! gqXgqXh<H?! Oleq! ouTk<kz<?! gVgqb! hz<Zl<! fiUl<?!
gib<s<sz<!-jth<Hl<!d{<miGl</!!
hi{<M!Ofibqe<!ujggt<!;!< < << < << < < !
! hz<OuX!sqk<k!lVk<Ku!F~x<gtqe<!nch<hjmbqz<!!






6/ lqVk<kqgi!hi{<M< << << <   !
















6/ l{<!kqe<xkiOzx<hm<m!hi{<M!< < < < << < < < << < < < < !







7/ l{<[e<!hi{<M< < << < << < < !
8/ wiq!hi{<M!










































6/ l{<hi{<M!< << << < !






























6/ lqVkqgih<Hg<kh<!hi{<M!< < < << < < << < < < !
!! -r<rel<! Olx<gi[l<! ! hz<OuX! F~z<gtqZl<! hi{<M! Ofibqe<! ! ujggt<!
uqiqk<K! %xh<hMgqxK/! -kqz<! l{<! d{<hke<! uqjtuig! d{<miGl<! hi{<M!
Ovigl<! hx<xq! hz<OuX! F~x<gtqZl<! -Vf<K! oktqk<K! Nb<uitviz<! Lcf<k!
ujvbqz<!kvh<hm<Mt<tK/!!
!
Gpf<jkgt<!Ofib<gt<!< < < << < < << < < < .!sqkl<hvk<ki[!hqt<jt< < << < << < < !




















!! ubqX! Dkz<?! ogih<Ht<! uQg<gl<?! Gmz<! uQg<gl<?! Okiz<! uxm<sq! gi[l<?!
uib<!dzIkz</!
!






!! GVkq! uif<kq?! g{<! ouTk<kz<?! dmz<! ouTk<kz<?! sqXfQi<g<gm<M?!
lzg<gm<M?!df<kqbqz<!fQi<!Osi<kz<!d{<migq!lv{l<!Wx<hMl</!!
!






!! dmz<! wjm! Gjxkz<?! &g<gqzqVf<K! -vk<kl<! uckz<?! g{<lR<st<! fqxlig!
liXl<?!!6!Lkz<!8!fim<gtqz<!lv{l<!Wx<hMl</!!
!

















l{<<<<[e<!ouTh<H!Ofib<< < << < << < <!
OuX!ohbI;!
!!!!! lqVk<kqg!hi{<M< << << < !!
nEhu!juk<kqb!Oku!vgsqbl<;< << << < !
l{<!hi{<M<;< < << < << < < !
!!!!!!l{<! sil<hz<! Lkzqbjugjt! fit<! OkiXl<! nVf<Kukqeiz<!
siqvk<kqZt<t! ne<evs! fvl<Hgt<! dzIf<K! vs! kiK! fsqf<K! nke<! giv{lib<!
vk<k!kiKUl<!fsqf<K!-f<Ofib<!d{<migqxK/!
!!!!!!-kqz<! fihq?! nz<Gz<?! hikl<?! Lgl<?! N{<Gxq! we<El<! -mr<gtqz<!
uQg<gLl<?!K{<MK{<mig!gqVlqs<!OsIf<k!lzLl<?!vk<kr<gzf<k!Ogijp!uif<kqBl<!
d{<miGl</!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.\/!sQk<kivil<!hqv^ik</Q < < <Q < < <Q < < < !
hvvisOsgv!juk<kqbg<!jgObM!hq{qbxqkz<;!< < << < << < < !
lqVk<kqgi!<<< hi{<M;<<< !
!! Lgl<?! Hxr<giz<! uQr<Gl<?! Lm<M?! -jth<H?! ofR<sqc?! l{<j{!
uqVl<hqB{<[l<?!ubqX!uql<Ll<?!lzk<kqz<!gqVlq!gi{h<hMl</!!
.lV/Os/squs{<Pgvi\i/<<< !
svOhf<kqv!juk<kq<b!Ljxgt<;< < < << < < << < < < !
l{<!kqe<xkiOzx<hm<m!hi{<M< < < < << < < < << < < < < !
 l{<!sih<hqMukqeiz<!uikikq!Oki]r<gt<!hqvOgihl<!njmgqxK/!!
 Kui<h<hie! l{<! uikk<jkBl<?! ]iv! G{Lt<t! duIl{<!
hqk<kk<jkBl<?! -eqh<hie! l{<! )filg<gm<c?! Ogihqsf<kel<?! osl<l{<!
Ohie<xju*!ghk<jkBl<!uqVk<kq!osb<Bl</!
 -keiz<! l{<! Ogi]<mk<kqz<! dt<t! ng<eqbiZl<?! kiKgtqe<!
ng<eqbiZl<! siqbiehc! sQv{qg<gh<hmilz<! nhg<uligq! vsua^<Ovi!
k^<^ Qgjt! fqvh<hq! njugjt! njmg<gqe<xK! fitjmuqz<!
-f<kqiqbr<gtqe<! hzk<jkg<! Gjxk<K?! uQiqbl<?! ng<gqeqhzl<?! ui<{l<?!
Lkzqbju!liXhm<Mh<!hi{<MOvigl<!sl<huqg<gqe<xK/!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! .lV/s/our<gm<mvi\e< << << < </!
hi{<M!<<< .!okimi<!Ofib<!;!< << << < !


















! ! ! ! ! ! .!lV/k/Olige<vi\</< << << < !
Lg<Gx<x!OuXhiMgt<;< < << < << < < !!
!!!!!!!!sqk<k! lVk<Ku! Ljxh<hc! dml<hieK! :7! kk<Kur<gtiz<!
Ng<gh<hm<mK/! kk<Kuk<kqz<! WOkEl<! lix<xl<! Wx<hMlieiz<! Ofib<! Wx<hMl</! Lkz<!
lix<xlieK! hR<sh,k! nch<hjmbqz<! Wx<hMl</! nke<hqe<! Lg<Gx<xl<! hikqg<Gl</!
hqe<ei<! kk<Kur<gt<! hikqg<gh<hMl</! kiKg<gTl<! lzr<gTl<! dmzqz<!
GxqG{r<gjt!d{<mig<Gl</!
hqk<kl<< << << <!
!




-vR<sg!hqk<kk<kqz<!d{<miGl<!lix<xl<< < < < < < < << < < < < < < << < < < < < < <!
d{uqe<!Ogm<miz<!-vs!GVkqgTg<G!Dm<ml<!ohxi/!)-vR<sghqk<kl<*!
!













uikl<!uiPlqml<< << << <!
!! nhiee<,! lzl?<! df<kqbqe<! gQp<,! &zl<?! Okiz<?! fvl<Hg<%m<ml?<! De?<!
hg<Guisbl<?!giK/!









u/w{<<<<! uikl<<<<! uikk<kqe<!< << << < osbz<<<<!
l{<[e<!ouTh<H!< < << < << < <






































































































!!!!!!!l{<[e<! ouTh<H! Ofibqz<! hqvi{e<<<<,! nhiee<<<<,! uqbiee<<<<,! dkiee<?<<< !
sliee<?!<<< !gqVgve<<<<,!Okukk<ke<< << << <,!Ngqbju!hikqg<gh<hm<Mt<tK/!
hqk<kl<;< << << < !
!!!!!!hi{<M! Ofib<! uv! Lkz<! giv{l<! hqk<kg<! Gx<xliGl</! hqk<kl<! uiPlqml<!
lx<Xl<!nke<!G{r<gjt!hx<xq!uqiquig!uqtg<gqBt<Ote</!
hqk<kl<!uiPlqml<< < << < << < <!
!!!!!!!hqr<gjz?! hqvi{uiB?! fQi<h<jh?! &zig<gqeq?! -Vkbl<?! kjz?! ogih<H,p<?!
df<kq?!-jvh<jh?!uqbi<ju?!fiuqZ~Xgqe<x!fQi<?!osf<fQi<?!sivl<?!g{<?!Okiz</!
hqk<kk<kqe<!ucuk<ke<jl< < < < << < < < << < < < < !
!!!!!!hqk<kk<kqe<!-bx<jg!ucul<!n[k<KuliGl<!
-bx<j<<< gh<!h{<H< << << < !



























































u/w{<<<<! !!hqk<kl<< << << <! !!hqk<kk<kqe<!osbz<< < < << < < << < < <!
l{<[e<!ouTh<H!< < << < << < <
Ofibqz<!<<< hqk<kk<kqe<!< < << < << < <
fqjz!











hikqh<H!)hsqbqe<jl!< << << <
d{<miGl<*< << << < !







hikqh<H!)g{<!out<uqpq< < << < << < < ?!
Okiz<!ouTk<kqVg<Gl*<< < < << < < << < < <!
!






hikqh<H!)g{<!out<uqpq< < << < << < < ?!
Okiz<!ouTk<kqVg<Gl<*< < < << < < << < < < !






hikqh<H!)ne<xim!< << << <
h{qgjt!siquv!osb<b!<<<
-bzilz<!dmz<Osii<U!< < << < << < <
d{<miGl<*< << << < !











!! l{<[e<! ouTh<H! Ofibqz<! nex<! hqk<kl<< < << < << < <,! -vR<sg! hqk<kl<< < << < << < <,! sikgh<!<<<
hqk<kl<< << << <,!hqvisg!hqk<kl<< << << <?!Ngqbju!hikqg<gh<hm<Mt<tK!
ghl<;<<< !








!! slieuiB! –! SpqLje! .! ouf<fQi<! .! Ng<gqje! .! fig<G! .! d{<{ig<G! .!
ogiPh<H! .! ls<js! –! GVkq! .! &g<G! .! lii<H! –! fvl<H! –! wZl<H! .! &jt! –!
ohVr<Gmz<!.!g{<!.!gQz<gt</!!
-bx<jgh<!h{<H;!< < << < << < < !








u/w{<<<<! ghl<<<<! ghk<kqe<!< << << < osbz<<<<!
l{<[e<!ouTh<H!< < << < << < <
Ofibqz<!<<< !
ghk<kqe<< << << <!fqjz!



































!! l{<[e<! ouTh<H! Ofibqz<! nuzl<hgl<< << << <?! gqOzkgl<<<<?! Ohikgl<! Ngqbju!
hikqg<gh<hm<Mt<tK/!
!!!!!!!!
osf<fQi<!dVuig<gl<!< Q < < << Q < < << Q < < < .!Okjvbi<!ogit<jg< << << < !
!!!!!!!!Lkz<! fit<! d{<m! d{uqeqe<Xl<! hqiqUx<x! ne<e! vslieK!
ne<jxg<G!-vs!kiKju!fjek<K!Dxq<k<!kr<Gl</!!









!!!!!ose<X! nk<kiKg<gjt! uqVk<kqbjmbs<! osb<K! wm<mil<! fit<! dmx<Gg<!
Ge<xik!ue<jljbg<!ogiMg<Gl</!
!!!!!!l{<[e<!ouTh<H!Ofibqz<!sivl<<<<?!osf<fQi<< Q << Q << Q <!hikqg<gh<hMgqxK!
hq{qbxqLjxjl!
!!!!!!hq{qbxq! Ljxjl! we<hK! dmjzh<! hq{qk<kzib! Ofijbk<!
okiqf<Kogit<Tgqx!yPg<gl<!weh<hMl</!


















!!!!!Ofibitq! ohbi<?ubK?! okipqz<?! -ml<?! GMl<h! $p<fqjz?! GMl<h! uvziX?!
Ofibqe<! gizl<?! Lf<jkb! uvziX?! giz! liXhiMgt<?! lVf<K! wMk<Kg<!
ogi{<mkx<gie! uvziX! lx<Xl<! hpg<gupg<gr<gt<! Ngqbux<xqje! Ofibitq!
nz<zK!ohx<Oxiiqml<!Ogm<M!ohXkz</!!
!
l{<[e<!ouTh<H< < << < << < < !Ofibqz<!w{<ujgk<!Oki<U< < < << < < << < < < !
w{<ujgk<!Oki<Ugt<< < < << < < << < < <!






















!!!!!hizi<gTg<G!< << << < fic!fjmbqe<!d{<jl!siqbigh<!Hzeigiuil</< < < << < < << < < < !
hi{<M!Ofibqe<!fic!fjm< << << < !
hqk<k!fic<<< !















Jb!hqk<kl<< << << <!
!! ouG!SvLl<!fiuxm<sq!hi{<M<<< !Ovigl<!!!!
















&k<kqvl<;< << << < !
sqXfQi<;Q <Q <Q < !
fQi<g<GxqQ < <Q < <Q < < .!l{<[e<!ouTh<H< < << < << < < !Ofibqz<<<<!
!!!!!!sqXfQi<!ntuqz<!GjxBl<!!




!! hi{<M!Ofibqz<!gkqi<!Ohiz<!hvUl</< < < < << < < < << < < < < !
hVugizr<gt<< << << <!
!! gii<! gizl<! lx<Xl<! %kqi<! gizl</! ! -u<uV! gizr<gtqz<! hqk<kl<! ke<eqjz!
uti<s<sq!lx<Xl<!Oux<Xfqjz!uti<s<sq!njmBl</!
fqzl<<<<!
!!!!!!GxqR<sq?! ofb<kz<! lx<Xl<! hijz! fqzk<kqz<! uiPl<! lg<gTg<G! l{<[e<!
ouTh<H!Ofib<!uVukx<gie!uib<h<Hgt<!dt<te/!!
!
nsik<kqb!GxqG{l<;< << << < !













svOhf<kqvi<!juk<kqb!Ljxgt<< < < << < < << < < <!
!! uQg<gk<kqz<! lR<st<! fqxl<! gi{h<hm<miz<! G{l<! Wx<hmiK/! lzsqg<gOzi!
nz<zK! hs<js! fqxlie! nkqsivOli! Wx<hm<miz<! nsik<kqbl</! hzuQel<?! uif<kq?!
&i<s<js! nkqg! fitie! hi{<M! Ovigl<! sqgqs<jsg<G! ush<hmiK! HkqkieiZl<!




!! hx<gt<?! fgl<?! g{<! -jugt<! nkqgl<! ouTk<kiZl<! wz<ziux<jxBl<!
ou{<{qxlig! hii<k<kiZl<! nf<k! Ovigl<! nsik<kqbliGl</! nsik<kqb! Ovigk<jk!
Lx<xqZl<! G{h<hMk<k! Lcbiuqm<miZl<! sqxqK! GxqG{r<gjt! Gjxk<K!
NBjtBl<!sqz!gizl<!fQcg<gs<!osb<bzil</!
!! jggt<?! giz<gt<?! kjz! Lkzie! -mr<gtqz<! uQg<gl<! Wx<hm<M! -jtk<K!
jggiz<gTl<! -jtk<K! ubqX! ohVk<Kl<! dt<t! hi{<M! OvigqjbBl<! N{<Gxq!




 fQck<K! okimi<uKl<! lqg<g! Lkqi<f<K! OhieKlie! hi{<M! sqgqs<jsg<G!
ush<hmiK!
 nubr<gt<! uQr<gqh<! Ohib<! wz<zih<! ohiVTl<! lR<stig! Okie<xqeiz<!
kQviK/!
 -Xgqb! osix<h! lzk<Kme<! lR<st<! fQvigUl<! ghk<Kme<! %cbkigUl<!
nkqsivl<!d{<mieiz<!nsik<kqbl</!
 nkqg! kQk<ke<jl! njmf<K! nubr<gt<! ou{<jlbigq! uif<kq! &i<s<js!
fiuxm<sq!d{<mieiz<!nsik<kqbl</!
 -vk<kl<!ogm<M!dmz<!Lx<Xl<!ouTk<kiz<!kQviK/!





lVk<Kuh<!hiqgivl<< < << < << < <!
!!!!! hq{qg<gh<hm<m! utq?! npz<?! ! Jbl<! we<El<! Lg<Gx<xk<jkk<!
ke<eqjzh<hMk<Kkz<! lVk<Kul<! we! upr<gh<hMl</! hq{qg<gh<hm<m! Lg<Gx<xr<gt<?!!
Jl<Hze<gt<?! WP! dmx<kiKg<gt<! Ngqbjugjt! ke<eqjzh<hMk<Kl<!
ke<jlBjmbju!lVf<kiGl</!









!! sqk<k! lVk<Ku! Ljxh<hc! Ofib<g<G! lm<Ml<! lVk<Kulqe<xq! nkje! uviK!
kMg<gUl<!gibgx<hligUl<!lVf<Kgt<!hbe<hMl</!
         “dx<xi!etUl<!hq{qbtUr<!gizLr<!
!!!!! gx<xie<!gVkqs<!osbz<”/!
!!!!!!!!!!!!!!!!!!!!!!!.kqVg<Gxt<<< <!
! Ofibqee<! njmf<k! Gx<x! OuXhiMgtqe<! lqGkz<! Gjxkz<! ntjuBl<!
nkeiz<! OfiBx<xie<! ohx<x! Ofibqe<! ntjuBl<! nxqf<khqe<! Ofibqe<! giz!
ntju!nxqf<K!sqf<kqk<K!kGf<k!lVk<Kul<!HiquK!nusqbl<!!
lVk<Ku<<< !upqLjx!
!!!!!!Ogmjmf<k! Lg<Gx<xl<?! uiBg<gt<?! -vk<kk<kiK! -kje! slh<hMk<Kl<!
lVf<Kgtig! -Vg<g! Ou{<Ml</! fil<! ogiMg<Gl<! lVf<KgtieK!
-vR<sgh<hqk<kk<jk! slh<hMk<kq! -vk<kk<kiKju! ke<! -bz<hie! Oujzgt<!
osb<ukig!lix<x!Ou{<Ml</!




!! nkqgiqk<k! hqk<kk<jk! ke<eqjzh<hMk<k! uif<kq! lVk<Kul<! osb<kz<!









!!!! -kx<gig! Nb<Ugm<Mjv! Nsqiqbi<!“sqXuqz<uikq! -tgl<< << << <”! ! wEl<! lVf<jk!
“l{<[e<!ouTh<H!< < << < << < < !Ofib<<<<”g<gig!wMk<Kt<tii</!
!
d{U;!
!! Ofib<! okimg<gk<kqz<! hsqjbk<K~{<mg<%cbKl<! dmzqe<! GVkqjb!
ohVg<gg<%cbKlie! d{Uh<! ohiVm<gjth<! ohiqKl<! jgbitz<! Ou{<Ml</!
d{Ul<!wtqkqz<!osiqg<gg<%cbkigOu!-Vk<kz<!Ou{<Ml</!





gib<gxqgt<< << << <;!
!!!!!!gk<kiqhqR<S?!LVr<jgh<!hqR<S?!uijpg<gs<sz<?!nujvh<hqR<S/!







!!!!!!!!!!!!!!!!!!!!!!!!!.!kqVg<Gxt<!< << << < !
! fil<! dm<ogit<Tl<! d{uieK! dmjz! ue<jlhMk<kg<%cbkigUl<?!
dmjz!gibg<gx<hlig!lix<xg<%cbkigUl<!-Vg<g!Ou{<Ml</!!!
 d{uqzqVf<K! gqjmg<Gl<! -Vl<Hs<sk<K! dmzqz<! dm<gqvgqg<gh<hm<m!
jum<mlqe<! “sq”! Okju/! jum<mlqe<! “sq”! fqjxf<k! d{Ugjt! Osi<k<K!
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           Anaemia is defined as a reduction of the hemoglobin concentration or red 
blood cell [RBC] volume below the range of values occurring in healthy persons. 
Which vary by age, sex, altitude, and pregnancy status. 
           Anaemia is a global public health problem affecting both developing and 
developed countries at all ages. 
         Anaemia is often multifactorial and is not an independent phenomenon. 
         Iron deficiency is the most common cause of nutritional Anaemia in the world. 
Although other conditions, such as Folate, Vitamin B12 and Vitamin A deficiencies, 
chronic inflammation, Parasitic infection (hookworm and malaria), and inherited 
disorders, blood loss due to trauma  can  cause Anaemia. 
         As of 2010 the global prevalence of Anaemia was approximately 32.9% . 
        Date from the 2005-2006 round of Indians national family health survey 
(NFHS) reveal that approximately 55% of women and 24% of men suffer from 
Anaemia. 
   Anaemia is the blood disorder, characterized by the reduction in: 
1. Red blood cell count (RBC) 
2. Hemoglobin content 
3. Packed cell volume(PCV) 
4. Mean Corpuscular Volume (MCV) 
5. Mean Corpuscular Hemoglobin (MCH) 
6. Mean Corpuscular Hemoglobin Concentration (MCHC) 
 
WHO CRITERIA FOR DIAGNOSIS OF ANAEMIA: 
  Hb % level based (October 8, 2018) 
 Children 6 months to 6 year : Less than 11gm Hb% 
 Children 6 years to 14 year: Less than 12gm Hb% 
                                          -   IAP TEXT BOOK OF PAEDIATRICS 
GRADING OF ANAEMIA: 
  WHO grades Anaemia according to hemoglobin level as follows  
 Hb between 10gm and cut off point for age: Mild 
 Hb between 7 to 10 gm: Moderate 
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 Hb  under 7gm : Severe 
 Hb under 5gm: very severe. 
ETIOLOGY OF ANAEMIA: 
            Causes vary with age and Anaemia may be multifactorial 
New Born: 
 Maternal infections 
 Maternal Anaemia 
 collagen vascular diseases 
 prematurity 
 Jaundice (hemolysis due to ABO or Rh incompatibility, G6PD 
deficiency, sepsis)  
 presents of hemangiomas or cephalhematoma 
 Result of blood loss(Antepartum haemorrhage, postpartum 
haemorrhage) 
 
Young infants (3 months to 18 months): 
          Infants may have physiological Anaemia at 2- 3 months of age. Delayed or 
inadequate weaning with predominantly milk- based diet results in poor iron intake, 
leading to nutritional iron deficiency, usually occurring at 6 months to 2 yrs of age; 
other causes include chronic diarrhea or cow milk allergy. 
             Megaloblastic Anaemia may be nutritional, due to use of goat milk in infants 
and a vegetarian diet in older children. 
 Physiological Anaemia(Normal variation of Hb and RBC and not a true 
Anaemia) 
 Iron deficiency Anaemia especially in prematures(with or without protein 
deficiency) 
Older babies and Children:  
Common Causes Less Common Causes 
 Malnutrition and iron deficiency  Leukemia 
 Infections 
 Inherited defects of RBC 




 Nephritis, Nephrosis 
 Bleeding disorders 
 Haemophilias 
 Thrombocytopenic purpura and  
petechial bleeding. 
 Ankylostomiasis 
 Rare causes-aplastic Anaemia, 
pernicious Anaemia. 
 
ETIO – PATHOGENESIS: 
Anaemia due to defects in haemoglobin synthesis 
              When there is deficiency of Iron, Vitamin B12, Vitamin C, Folic acid, 
Pyridoxine, Thyroxine, Proteins and Copper there is decreased haemoglobin 
synthesis. 
Anaemia due to immaturation of red blood cells: 
              In megaloblastic Anaemia large nucleated red blood cells are seen in the red 
marrow of the bones. This immaturation is due to non-availability of Vitamin B12, 
Folic Acid. 
Anaemia due to Red Blood cell defects: 
               The life span of matured red blood cells is about 120 days. Sometimes they 
may die within their usual lifetime. This leads to Anaemia. 
 
PATHOPHYSIOLOGY OF ANAEMIA: 
            Subnormal level of haemoglobin causes lowered oxygen carrying capacity of 
the blood which leads to hypoxia in organs. 
 Increased release of oxygen from haemoglobin 
 Increased blood flow to tissues 
 Maintenance of the blood volume 
 Redistribution of blood flow to maintain the cerebral blood supply.  
CLASSIFICATION OF ANAEMIA 
         Anaemia is classified by two methods: 
1. Morphological classification 
2. Etiological classification 
MORPHOLOGICAL CLASSIFICATION 
  Morphological classification depends upon the size and color of RBC. Size is 
determined by mean corpuscular volume (MCV). Color is determined by mean 
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corpuscular hemoglobin concentration (MCHC). By this method Anaemia is 
classified into four types. 
1. Normocytic Normochromic Anaemia 
2. Macrocytic Normochromic Anaemia 
3. Macrocytic Hypochromic Anaemia 
4. Microcytic Hypochromic Anaemia 
Normocytic Normochromic Anaemia: 
 Size and color of RBCs are normal. But the number of RBC is less.  
 Post-hemorrhage - early stage  
 Hemolytic Anaemia  
 Iron Deficiency Anaemia - early stage  
 Systemic diseases like endocrinal, renal and hepatic diseases  
 Bone marrow disorders like hypoplastic Anaemia, myeloinfiltration, 
dyserythropoiesis, myelodysplasia and masked megaloblastosis. 
Macrocytic Normochromic Anaemia  
  RBCs are larger in size with normal color, RBC count is less. Folate and 
Vitamin B12 deficiency, hypothyroidism. 
Macrocytic Hypochromic Anaemia 
  RBCs are larger in size. MCHC is less, so the cells are pale. Combined 
deficiency of Iron and folate or Vitamin B12 
Microcytic Hypochromic Anaemia 
 RBCs are smaller in size with less color. 
 Iron deficiency Anaemia 
 Haemolytic Anaemia 
 Haemoglobinopathies 
ETIOLOGICAL CLASSIFICATION 
  On the basis of etiology Anaemia is divided into five types 
1. Hemorrhagic Anaemia 
2. Hemolytic Anaemia 
3. Nutrition deficiency Anaemia 
4. Aplastic Anaemia 





PATHOLOGICAL RED BLOOD CELLS IN ANAEMIA 
  In Anaemia, many kinds of abnormal red cells including nucleated forms are 
seen in the circulation. These abnormal cells are: 
I. Anisocytosis(Variation in size of RBC): 
Macrocytosis: 
       The size of the cell is 9 to 12 microns.  This occurs in pernicious Anaemia, 
Plumbism, acute Anaemia due to severe haemorrhage and erythroblastosis foetalis. 
Microcytosis: 
     The size is less than 6 microns.  This occurs in iron deficiency Anaemia 
chronic bleeding, polycythaemia and Anaemia’s secondary infections. 
Normocytosis: 
           The red cells are is normal size, found mainly in pest haemorrhagic Anaemia.   
 
II. Pokilocytosis (Variation in shape of RBC): 
Ovalocytosis: 
  The oval shaped red cells occur in some human families. Such a condition 
does not cause ill health, but a minority may manifest haemolytic phenomena. 
Spherocytosis: 
        Spherocytosis may be seen incongenital haemolytic Anaemia and in certain 
other acute haemolytic Anaemias. The red cells are very fragile. 
Sickle cells: 
        In arterial blood, the red blood cells are normal in shape, but in venous blood. 
Some cells assume the shape of sickle. 
 
III. Polychromatophilia (Irregularity in staining): 
         This indicates an increase in immature red cells in circulation and occurs in the 
following forms: 
Normoblasts: 
       Nucleated red cell indicates over activity of bone marrow, commonly seen in 
severe Anaemia. 
Patchy staining of the cells: 





Punctate Basophilia(Basophilic stippling): 
It occurs in lead poisoning and severe Anaemia, and chronic malaria. 
Reticulocytes: 
            Occurs in acute bleeding and in pernicious Anaemia. 
 
SYMPTOMS AND SIGNS OF ANAEMIA: 
SYMPTOMS: 
 Inability to concentrate 
 Weakness 
 Headache 




 Dyspnoea on exertion 




 Anginal pain 
 Paresthesia in fingers and toes 
 Palpitation 
 Loss of appetite 
 Mental apathy 
 Constipation 
 Abdominal distension 
 Hair loss 
 Exercise in tolerance 
SIGNS: 
 Pallor of the skin, Mucous membrane, palms, nails and conjunctiva 
 Smooth, pale, glossy tongue 








 High volume pulse 
 Haemic murmur  
 Oedema 
 Hepatospleenomegaly 
 A mid-systolic ‘flow’ murmur, chiefly in the pulmonary area, is appreciated 
when the degree of Anaemia increases, reflecting increased blood flow across 
heart valves. Systolic bruits and postural hypotension may be noted with 
moderate to severe Anaemia. 
 Severe Anaemia is characterized by a high output state with an elevated pulse 
pressure and a ‘collapsing’ pulse. Anaemia may participate heart failure even 





IRON DEFICIENCY ANAEMIA 
              Iron deficiency Anaemia occurs when the decrease in total iron body content 
is severe enough to diminish erythropoiesis and cause Anaemia. The numbers are 
staggering; 2 billion – over 30% of the world’s population – are anemic, many due to 
iron deficiency. The major factors which influence its prevalence include poor socio-
economic status, low dietary intake, poor accessibility to healthcare facilities and 
worm infestation in the population. 
Iron requirements during childhood 
           Understanding of iron requirements, intakes and bioavailability is essential to 
explain the vulnerability of some individuals to develop iron deficiency Anaemia. 
           The iron released from the senescent, red cells during the first 8- 12 weeks of 
life(a period of quiescent erythropoiesis) is stored in the body and helps to maintain 
erythropoiesis upto 4-6 months in a normal term infant and upto 2-3 months in low 
birth weight infant. Normal infants at birth have about 75 mg of iron per kg body 
weight, two thirds of which is present in red blood cells. Infants and children should 
continue to absorb 0.8 to 1.0 mg of iron daily to reach the adult body stores of 4-
5gms. 
          Normal body losses of iron are about 20g/kg/day and most of these losses 
occur by the shedding of cells from intestinal mucosa. These losses are small and are 
relatively constant but may increase many folds in the presence of diarrhea, dysentery, 
and parasitic infections. 
          Certain factors protect infants from becoming iron deficient in first few 
months of life. These includes 
 Preferential delivery of iron to the fetus during the pregnancy particularly 
during last three months of gestation 
 Placental transform to the newborn immediately after birth when the cord is 
allowed to pulsate before being clamped. 
 Exclusive breast feeding for first four to six months of life, due to better 
bioavilability of iron from the breast milk. 
 
Structures of the red corpuscles in IDA 
         In Iron Deficiency Anaemia, the red blood corpuscles are decreased or normal in 
the number and hemoglobin content is reduced. In the smear, the red cells appear pale 
with a large central pale area and many of the red blood cells appear to be smaller 
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  The etiology varies with the age, sex and country of residence of the patient 
Etiological factors in iron deficiency Anaemia 
Increased physiological requirement 
 Rapid growth- infants and preadolescence 
 Menstruation 
 Pregnancy 
Decreased  iron stores 
 Preterms 
 Small for dates 
 Twins 
Decreased iron assimilation 
 Iron poor diet 
 Iron malabsorption 
 Sprue 
 Pica 
 GI surgery 
 Chronic diarrhea 
 Delayed weaning 
 Malnutrition 
Blood loss 
 Gastro intestinal bleeding 
 Milk induced enteropathy 
 Peptic ulcer disease 
 Inflammatory bowel disease 
 Drugs- salicylates 
 Hook worm infestation 
 Fetal Maternal transfusion 
 Iatrogenic 
 Bleeding diasthesis 





 Low birth weight 
 Recovery from PEM 
 Adolescence 
Iron poor diet 
 Dietary inadequacy is present in more than 80 % of cases especially in the 
poorer groups. This is still encountered in privileged societies under the 
following circumstances. 
 Infants are also at high risk because the diet predominantly milk contains 
very small amounts of iron. Human milk provides only about 0.3mg / litre 
of iron. 
 Premature babies have only lesser amount of storage iron in the liver as 
well as body 
 Children especially during the early years of life have a need for dietary 
iron to accommodate growth and expansion of the blood volume. 
 
Iron malabsorption 
 Iron malabsorption is an unusual cause of iron deficiency where 
malnutrition is rampant however both histologic and functional 
abnormalities of the intestine are common. Defective iron absorption is 
caused by non- tropical sprue. 
 Partial or total gastrectomy impairs iron absorption caused by reduction in 
gastric acidity and acceleration of the food through the upper portion of the 
small bowel. The absorption of both haem iron and non-haem is defective. 
 Pica or the habitual ingestion of non-food substances is common in 
children and pregnant women. It markedly inhibits iron absorption. 
 Pancreatic enzymes may contribute to the high incidence of iron 








Gastro intestinal bleeding: 
 
Fig.no.1 
 Hookworm infestation (Ankylostomiasis) is the most important cause of 
intestinal blood loss worldwide. The parasites Ankylostoma duodenale and 
Nectar americanus attach to the proximal portion of the small intestine and 
suck blood from submucosal vessels. The amount of blood lost is a function of 
the hookworm load, which in turn is proportional to the number of ova in the 
stool. Each worm has been in the intestine for months or years, draws, 0.2-0.5 
ml of blood per day. It has been estimated that the loss of hemoglobin for 
every twelve worms may be one percent. Fecal ova counts in excess of 5000/g 
are regularly associated with iron loss of more than 3 to 4 mg/day and a high 
incidence of iron deficiency Anaemia. 
 Milk induced enteropathy associated with occult Gastrointestinal bleeding has 
been implicated as the cause of iron deficiency in some infants. 
 During the first year of life, meckel diverticulum is a well- recognized cause 
of asymptomatic bleeding in adult men and postmenopausal women, occult 
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bleeding from the gastrointestinal tract is the most common cause of iron 
deficiency. 
 Gastrointestinal bleeding also is prevalent among iron deficiency infants and 
children. Characteristically gastro intestinal bleeding is occult and 
unsuspected. 
 Peptic ulcer disease is a well – documented cause of occult blood loss. 
 Crohn’s disease and ulcerativecolitis also are commonly associated with iron 
deficiency. 
 Corticosteroids, Indomethacin and other non- steroidal anti-inflammatory 
agents may also induce gastrointestinal tract bleeding. 
 
Pathogenesis: 
               Iron deficiency Anaemia develops when iron supply to the bone marrow is 
insufficient for the erythropoiesis. 
                It has been stated that the body is normally in a state of positive iron 
balance. When a negative iron balance occurs due to blood loss, increased 
requirements or impaired absorption, the deficit is made good by iron mobilized from 
the tissues and an adequate supply of iron for haemoglobin formation is maintained. It 
is only when the tissue stores are exhausted that the supply of iron to the marrow for 
haemoglobin synthesis becomes inadequate and hypochromic Anaemia develops. 
    Thus iron deficiency may be regarded as developing two stages. 
 The progressive depletion and culitivate exhaustion of the available tissue 
iron stores 
 Iron deficiency state, which may be divided into three distinct stage of 
severity. 
Stage Manifestation 
Early stage Storage iron depletion 
Second stage Iron limited erythropoiesis 





Stages of iron deficiency Anaemia 
1. Storage of iron Depletion 
  Iron reserve is small or absent and is characterized by reduced serum ferritin 
or reduced iron concentration in marrow and liver tissue. Haemoglobin and serum 
iron, Transferritin concentration and saturation are within normallimits 
2. Iron limited Erythropoiesis 
  Haemoglobin (Hb) may still be normal but serum iron is low and TIBC 
increased with a low serum ferritin and raised free erythrocyte protoporphyrin (FEP) 
3. Iron deficiency Anaemia 
  The flow of iron to erythoid marrow is impaired to cause reduction in 
haemoglobin concentration with a progressive microcytic hypochromic Anaemia 
associated with reduced serum iron, transferring saturation and serum ferritin level. 
Role of iron deficiency Anaemia in various systems 
Cardiovascular system 
           Dyspnoea and palpitation are common symtoms while on exertion but in very 
severe Anaemia the patient may get cardiac failure and there may be dyspnoea at rest. 
Haemic murmurs are commonly heard in anemic patients. The murmurs are most 
often mild systolic murmurs heard at the mitral area. 
            Systolic bruits over the carotid arteries in the neck are sometimes present in 
anaemia usually they are bilateral and occur in the absence of an aortic systolic bruit 
and disappear following correction of the anaemia. Jugular venous pressure increase 
in severe  anaemia due to high pulse pressure with a capillary pulsation. Oedema of 
the legs occasionally occurs in ambulant patient with severe anaemia as the result of 
venous capillary pressure on exertion and increased capillary permeability. 
Central nervous system 
          Symptoms include faintness, giddiness, headache, roaring in the ears, tinnitus, 
spots before the eyes, lack of concentration, drowsiness and with severe anaemia 
clouding of consciousness, numbness and sometimes tingling of the hands and feet. 
Reproductive system 
      Menstrual disturbances are commonly associated with anaemia 
Renal system 
      Slight proteinuria may be present with severe anaemia. Anaemia may further 
reduce renal function at which nitrogen retention develops; correction of anaemia in 
such patient is usually followed by a fall in blood urea. 
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Gastro intestinal system 
         Anorexia is the commonest symptom, nausea, flatulence and constipation may 
also occur. Slight to moderate smooth hepatomegaly is common in severe anaemia 
and when congestive cardiac failure develops. The liver may become tender. In 
certain cases of Iron deficiency anaemia spleen may be enlarged 
Pyrexia 
         Mild pyrexia may occur with severe anaemia but marked fever is due to either 
the causative disorder or due to some complicating factor.  
DIETRY IRON: 
  The dietry iron comes from two sources, Heme and non-heme, the later being 
the major source of iron in diet and is found in varying degrees in all foods of plant 
origin. Heme iron is present in meat, fish and poultry but low. Heme iron is better 
absorbed than non-heme iron and is not influenced by dietry factors. 
  Breast milk even in spite of low levels of iron (0.5mg/lit) has a better 
absorption and bioavailability as compared to cow’s milk.  Good sources of iron in 
the diet includes, pulses, dhals, green leafy vegetables, dates, nuts, jiggery, meat and 
fish.  Administration of 50mg of vitamin C increases iron absorption by two folds. 
Complication of iron deficiency Anaemia 
 In patients with heart disease severe anaemia may precipitate angina 
pectoris or congestive heart failure 
 Infections are more common in Iron deficiency anaemia, especially those 
of respiratory, gastrointestinal and urinary tracts. 
 Growth problems: In infants and children, severe iron deficiency can lead 
to anaemia as well as delayed growth and development. 
Investigation required for iron deficiency Anaemia 
Blood investigation 
 Total red blood cell count 
 Differential count 
 Erythrocyte sedimentation rate 
 Mean corpuscular volume (MCV) 
 Mean corpuscular hemoglobin concentration (MCHC) 
 Packed cell volume (PCV) 
 Peripheral blood smear 
 Red cell survival 
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 Serum iron 
 Serum ferritin concentration 
 Serum protein 
 Serum creatinine. 
Urine investigation 
 Urine sugar 
 Albumin 
 Deposits 
 Red blood cells 
 Pus cells 
Stool investigation 




 Red blood cells 
 Pus cells 
Special investigations occasionally required 
 X- ray barium meal, X-ray barium enema, X-ray Chest 
 Endoscopy, Colonoscopy, Sigmoidoscopy, Gastroduodenoscopy 
 Isotope studies 
 Skeletal survey for multiple myeloma and secondary deposits 
 Bone marrow examination 
 Liver function test 
 Jejunal biopsy, urography, selective angiography 
 Ultrasonography 
 LABORATORY DIAGNOSIS: 
               In Iron deficiency anaemia the haemoglobin is less than 11 gm in children.  
The red cell count in rarely below 2.5 million/cubic millimetre and the red cells are 
usuall microcytic and hypochromic reticulocytes and platelets are normal or 
increased.  The white cell count is normal. Serum iron is usually below 30mg/100ml. 
(Normal is 250-350mg/100ml).  Bone marrow haemosiderin is absent.  The PCV, 





1. Anaemia of infection 
2. Pyridoxine (vit B6) deficiency Anaemia 
3. Haemoglobinopathies 
4. Sideroblastic Anaemia 
5. Anaemia of lead poisoning  
 
Anaemia of infection: 
        Chronic infections such as rheumatic fever, rheumatoid arthritis, tuberculosis 
and malaria may have associated with mild to moderate anaemia, which is 
normochromic or slightly hypochromic, serum iron is low, total iron binding capacity 
is also decreased.  Bone marrow haemosiderin is present. 
Pyridoxine(Vit B6) Deficiency Anaemia: 
         It is characterized by severe hypochromic microcytic anaemia, often early in 
infancy and progressive hepatospleenomegaly.  There is elevation of serum iron. 
Marrow shows erythroid hyperplasia with nucleated normoblasts containing iron 
inclusions, they so-called sideroblass in abundance.  There are abnormalities of 
tryptophan metabolism. 
Some Haemoglobinopathies: 
          In haemoglobin abnormalities like thalassemia, the red cells are microcytic 
and hypochromic.  Thalassemia minor is distinguished by normal serum iron, normal 
total iron binding capacity, decreased mean corpuscular capacity, normal serum 
ferritin volume, normal serum ferritin and transferring iron saturation. 
Sideroblastic Anaemia: 
          Most of the red cells are hypochromic and microcytic, serum iron is high and 
iron deposit in the marrow, liver and spleen and excessive. Many erythrocytes and 
erythroblasts contain non haemoglobin iron(ringed sideroblasts) in their mitochondria.  
The spleen is usually enlarged. 
Anaemia of lead poisoning: 
            Anaemia of lead poisoning is hypochromic and microcytic and may be 
moderate to severe. Basophilc stippling of red cells, which helps to differentiate it 
from iron deficiency anaemia pronounced increase of aminolevulinic acid and 
coproporphyrin in the urine is characteristic of lead poisoning. Increased levels of 




  Following criteria are essential to diagnose Iron deficiency anaemia 
 History of inadequate intake of dietary iron and blood loss if any. 
 Typical symptoms and signs like easy fatiguability, pallor, pica, 
koilonychias, smooth tongue, cheilosis, and dysphagia associated with 
general considerations. 
 Hypochromic and microcytic structure of red blood cells 
 Low serum iron, increased total iron binding capacity. 
 Bone marrow hemosiderin absent 
 Blood loss usually occult 
 Platelet count is either normal or raised 
 Hemoglobin estimation variably reduced 
 Reduced mean cell volume 
 Erythrocyte count may be normal or reduced 
 Serum ferritin level is reduced 
 
MANAGEMENT 
  Management of IDA is considered by three methods 
 Correction of anemic state 
           Over all correction of nutrition with articles rich in iron is important.  Iron 
deficiency is corrected by intake of rich iron content diet and administration of 
medicinal iron. 
 Replenishment of iron stores 
 Elimination of the cause 
PROPHYLAXIS 
  The main principles in the prevention of nutritional Iron deficiency                
anaemia are, 
 The regular consumption of a well balanced diet containing an adequate 
quantity of iron 
 The periodic administration of iron as drug during increased physiological 
needs such as rapid growth during infancy and preadolescence, pregnancy, 
lactation and menstruation. 
 Maintenance of a normal hemoglobin level in the mother for the 
prevention of iron deficiency anaemia in infants. Premature and unduly 
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small infants should be given prophylactic iron as a routine therapy. Iron 
rich sources should be added in the infants diet from the third or fourth 
month and thereafter be progressively increased.  
PREVENTION OF IRON DEFICIENCY ANAEMIA (IDA) 
  The basic approaches to the prevention of IDA include 
1. Protection and promotion of breast- feeding for as long as possible along 
with timely weaning is effective in preventing IDA Low birth weight 
infants need iron supplementation from the age of 2 months. 
2. Dietary modification and consumption of larger amounts of habitual foods 
increases total iron consumption by 25- 30 percent. Processes like 
germination, consumption and green leafy vegetables would be additional 
long-term methods for prevention of IDA. 
3. Periodic deworming with anti-helminthic drugs for hookworm infestation 
and schistosomiasis should be considered in endemic areas. 
4. Supplementation with medicinal iron is considered necessary to reduce the 
extent of anaemia in developing countries. 
5. Food and salt fortification with iron are evolving rapidly and would be one 
of the most effective ways to control IDA. Salt fortification gives an iron 
content of 1 mg per gram of salt in the preparation. 
DIET 
Haem iron sources 
 Muscle meat (red more than white) 
 Organ meat(e.g Liver) 
 Fish and shellfish 
 Poultry 




 Dried fruit 
 Whole meat 
 Bread, eggs 
 Green leafy vegetables 
 Iron fortified cereal foods 
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 Jaggery and yeast 
 Foods rich in vitamin C enhance iron absorption. 
Self care procedures for Iron deficiency Anaemia 
1. Eat more foods that are good sources of iron 
2. Concentrate on green leafy vegetables, red meat, beef liver, poultry, fish, 
wheat germ, oysters, dried fruit, and fortified cereals 
3. Foods high in vitamin C like citrus fruits, tomatoes and strawberries help the 
body absorbing iron from food 
4. Red meat not only supplies a good amount of iron, it also increases absorption 
of iron from other food sources 
5. Take an iron supplement 
6. Increased dietary fibre to prevent constipation 
7. Avoid aspirin and products with aspirin 
8. Eat fresh uncooked fruits and vegetables often. Don’t overcook food that 
destroys folic acid. 
9. Avoid bare foot  
10. Personal hygiene should be maintained such as, washing hands, trim 
fingernails…  
 










3. MATERIALS AND METHODS 
  To find the efficacy of SIRU VILVATHI ELAGAM, the following studies 
were carried out in the present investigation. 
1. Collection, Identification and confirmation of the raw drugs, for the 
preparation of trail drug 
2. Preparation of trail drug 
3. Biochemical analysis of trail drug 
4. Pharmacological studies of trail drug. 
5. Microbiology analysis of trail drug. 
6. Clinical trail 
          The clinical study on “MANNUN VELUPPU NOI” is being conducted in the 
OUT PATIENT and IN PATIENT of Postgraduate Department of Kuzhanthai 
Maruthuvam at Government Siddha Medical College and Hospital, Palayamkottai. 
Selection of cases 
 Patients reporting with symptoms of inclusion criteria will be subject to 
screening test and documented using screening proforma. 20 IN PATIENTS and 20 
OUT PATIENTS are selected. IN PATIENTS will be given medicine and provided 
hospital diet. OUT PATIENTS will be provided by medicine and advice for dietary 
regulations. 
Inclusion criteria 
 Age  : 5 to 12 years 
 Sex  : Both male and female children 
 Hb  level between 7-10 gms. 





 Worm infestation 
 Anaemia due to iron deficiency. 
 Families with poor economic status 
 Having perverse taste to eat mud, sand, ash, etc or increased food cravings 
(pica) 
 Brittle nails 
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 Shortness of breath 
 Palpitation 
 Patients willing to give blood and urine sample for lab investigations 
whenever required 
 Informed written consent given by parents/guardian of the patients. 
Exclusion criteria 
 Hb less than 7 
 Patients with chronic infection 
 Morethan age of 12 years 
 Renal and liver diseases 
 Bleeding disorder 
 Malignancy of any type(Thalassemia major, Aplastic Anaemia, Sicklecell 
Anaemia, Hemolytic Anaemia) 
 Rheumatic fever 
 Nephrotic syndrome 
 Tuberculosis 
Withdrawal criteria 
 Occurrence of any adverse reactions 
 Patients turned unwilling to continue in the course of clinical trial 
 Poor patient compliance 
Study of clinical diagnosis 
 A case sheet was prepared on the basis of Siddha methodology and modern 
methodology to diagnose the disease. An individual case sheet was maintained for 
each and every patient. 
 A complete history of the patient was taken. Name, Age, Sex, History of 
present and past illness, Antenatal, Neonatal and postnatal history, personal and 
dietetic history, family history and Socio-economic status were noted. 
 Siddha diagnosis was made on the basis of Envagaithervugal, Mukkutram and 
Ezhuudalkattukal. 





Tests and assessments 







 Pallor of skin, nail beds, palms, conjunctiva and mucous membrane 





 Heamic murmur 
 Angular stomatitis 
 Worm infestation  
 Anorexia 
Laboratory assessment 
  The Modern diagnostic tests such as blood test for TC, DC, ESR, Hb, PCV, 
MCV, MCH, MCHC, Peripheral blood smear, etc., urine analysis for albumin, sugar, 
deposits, etc., and stool examination for ova, cyst, occult blood to rule out any 
existing illness, before and after treatment. 
Administration of Trial Medicine: 
    The trial drug was prepared carefully. 
 Before starting the treatment deworming was done with Nilavagai choornam – 
3gms Od at night with hot water for 3-5 days. “SIRU VILVATHI ELAGAM" 2.5gm 
after food for 27 days was given to all the 40 patients two times a day during their 
treatment period. 
  The Biochemical analysis of trial drug was carried out in Department of 
Biochemistry, Government Siddha Medical College and Hospital, palayamkottai.   
             The pharmacological analysis for Haematinic and Hepatoprotective activity 
of the drug was done  in the pharmacological laboratory, Arulmigu kalasalingam 
college of pharmacy, krishnankoil. 
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              Anti Microbial study for pesudomonas aeruginosa and Escherichia coli 
was done in Malar Daignostic centre, Tirunelveli. 
             Observations were made from the 40 patients with signs and symptoms of the 
disease were recorded. In addition to medicine the patients were advised to take iron-






























PREPARATION OF TRIAL MEDICINE AND DRUG REVIEW 
lVf<kqe<!ohbi<!< < << < << < < ;!sqXuqz<uikq!-tgl<< << << <!
OsVl<!svg<Ggt<!;< < << < << < < !
)n *!!
uqz<uOui<h<hm<jm! ! .!!! 31!hzl<!
k{<{Qi<! ! ! .! 5!hc!
ouz<zl<!!!!!!!!!!! .!!! 31!hzl<!
wZlqs<sl<hps<siX! ! .!!! 21!hzl<!
-R<sqs<siX! ! ! .!!! 21!hzl<!
)N*!
!!!! Wziqsq!!! !!!!!! .!!! ¼!hzl<!!
! -zur<gl<! ! ! .!!! ¼  hzl<!
! Olx<Okiz<!sQuqe!Sg<G!! .!! ¼  hzl<!
! lqtG! ! !!!!!! .!!!! ¼  hzl<! !
! niqsqk<kqh<hqzq!!!!!!! .!!!! ¼  hzl<! !
!!!!!-zur<gh<hk<kqiq!!!! ! .!!!! ¼  hzl<!
!!!!!sqXfigh<H,!!!!!!!! !! .!!! ¼  hzl<!
!!!!!kitqsh<hk<kqiq!!!!!!! .!!!! ¼  hzl<!
!!!!!ogik<Klz<zq!uqjk!!! .!!! ¼  hzl<!
!!!!!sikqg<gib<!!!!!!!!!! .!!! ¼  hzl<!
!!!!!ofz<zqLt<tq!!!!!!!! .!!! ¼  hzl<!
!!!!!hVk<kquqjkh<!hVh<H!!! .!!! ¼  hzl<!
!!!!!oum<cOui<!!!!!!!!!! .!!! ¼  hzl<!
!!!!!uqzilqs<sl<Oui<!!!!!!! .!!! ¼  hzl<!
!!!!!ofx<!ohixq!!!!!!!!!! .!!! ¼  hzl<!
! Oke<! ! ! ! .! 9!hzl<!
!
osb<Ljx!;<<< !
!!!!!!!uqz<uOui<h<hm<jmjb! kiqk<kqck<K! yV! hi{<mk<kqzqm<M! fiZhc! k{<{Qi<!
uqm<M! wm<coziV! higligs<! S{<mg<! gib<s<sq! ucgm<c! juk<Kg<! ogit<tUl</!
wZlqs<sl<hps<siX?! -R<sqs<siX! -jugjtBl<! Olx<hc! GcfQVme<! gzf<K! nkqz<!
ouz<zk<jk! gjvk<K! nMh<Ohx<xqs<! sqX! kQbig! wiqk<Kh<! hiGhk<kqz<! )N*uqZt<t!
K~jtg<!ogiR<sl<!ogiR<sligk<!K~uqg<!gq{<cg<gqtxq!!wz<zil<!fe<xigg<!gzf<k!


















2/!uqz<u<<< Oui<< <<h<< <<hm<jm;!<<< !
!!!!    SYNONYMS           ;! Gsikhq,!%uqtl,<!%uqjt,!!
squk<KVll<,!fqe<mzq,liKvl<!
! BOTANICAL NAME        : Aegle marmelos 
 FAMILY            : Rutaceae 
 PART USED            : Root Bark 
           CHARACTERS: 
      Sju   : Kui<h<H,  jgh<H!
     ke<jl             : km<hl<!








         Ge<ll<,! Lg<Gx<xk<kqe<! OgM,! Osijh,! Jbk<kiZ{<mie! fQi<Oum<jg,! Svl<,!
fQOvx<xl<?!Lh<hq{q,!dmz<!gMh<H!-jugjtBl<!fQg<Gl</!
!!!!!!!hsQk<kQg<OgM,! Sjubqe<jl,! ohVr<gpqs<sz,<! uqg<gz<?! npz<?! Svl<!










           Fagarin, Marmin, Skimmianine, Maresin, Umbelliferine, alkaloids- 
dimethylallyl, 4-methoxyphenyl, dimethylallyloxy, ethykinnamamide. 






! SYNONYMS              ;! NR<sq?!Ogivr<gl<?!Kc!
! BOTANICAL NAME  : Elettaria cardamomum 
 FAMILY   : Zingiberaceae 
 PART USED              : Seed 
           CHARACTERS: 
       Sju                      :          gii<h<H!
   ke<jl                 :  ouh<hl<!










! ! ! ! ! ! .Okjvbi<!G{uigml</< << << < !
 G{l<<<<: 
! oki{<jm?! kit<?! uib<?! gQp<uib<! -jugtqz<! d{<miGl<! Ofib<gjtBl<?!









  Fixed oil, essential oil, volatile oil, Terpinyl acetate, cineole, free terpineol, 
alpha terpinyl acetate, linalool, limonene, myrcene, manganese, potassium, starch, 
nitrogenous mucilage, ligneous fibre.  






  SYNONYMS   ;! nR<Sgl<?!dx<gml<?!-zur<gl<?!!
! ! ! ! ! ! Osisl<?!kqvtq?!uvir<gl<?!gVuib<!!
gqvil<H/!
BOTANICAL NAME  : Syzygium aromaticum 
 FAMILY   : Myrtaceae 
 PART USED              : Bud 
           CHARACTERS: 
   Sju               : gii<h<H, uqXuXh<H!
   ke<jl              : ouh<hl<!











.ngk<kqbi<!< << << < G{uigml</<<< !
  G{l<<<<: 
! lbg<gl<?! Ohkq?! uif<kq?! GVkqg<gpqs<sz<?! fim<hm<mgpqs<sz<?! wVuib<g<gMh<H?!




















! BOTANICAL NAME        : Zingiber officinale 
 FAMILY           :   Zingeberaceae 
 PART USED           : Rhizome 
            CHARACTERS: 
     Sju   : gii<h<H!
     ke<jl                    :      ouh<hl<!






!!!!!!!!!!!!!!!!!!!!!!.!ngk<kqbi<!G{uigml<< < << < << < <!
  G{l<<<<: 
!! osiqbijl?! liIohiqs<sz<?! HtqObh<hl<?! ouh<hl<?! gQp<uib<! Ofib<?! -jvh<H?!







CHEMICAL CONSTITUENTS:      
           Zingiberene, Zingiberols, Sesquiterpen,B bisabolene,  Curcumene, 
Monoterpens,  Geranial, Neral, zingirone, ginerdoils, gingerols, D-camphor, 
farnensena. 
   Zingiberin that dissolves parasites and their eggs. 
  It contains Iron, calcium, phosphorus, carotene, thiamine, vitamin C, niacin 






lqiqbz<?! sVlhf<kl<?! ut<tqsl<?! lisl<?!
GXlqtG?!ljzbitq/!
! BOTANICAL NAME  :    Piper nigrum 
 FAMILY              :    Piperaceae 
 PART USED              :    Dried unripe fruits 
           CHARACTERS: 
 !!!! Sju   :   jgh<H!gii<h<H    
        ke<jl              :    ouh<hl<  
        hqiqU              :     gii<h<H!










!!!!!!!!!!!!!!!!! ! ! ! .!Okjvbi<!G{uigml</< << << < !
G{l<;<<< !
!! lqtgqeiz<! Gtqi<Svl<?! hi{<M?! Ogijp?! gpqs<sz<?! Ge<ll<?! uiB?!
Sjubqe<jl?! ouxq?! ! &zl<?! se<eqbisl<?! nh^<livl<?! hqvOlgl<?! -Vlz<?!















CHEMICAL CONSTITUENTS:   
  Piperine, Piperidine, Voltaile, Essential oil, phenolic amino acids, alpha 
tocopherol, feruperine, butylated hydroxytoluene, butylated hydroxyanisole. 
 Minerals such as potassium, calcium, zinc, manganese, iron, magnesium, 
copper. Vitamin – A, C, E, K.  
 
6. niqsqk<kqh<hqzq;< << << <  
!!!!SYNONYMS        :          Ni<gkq?!d{<svl<?!dzjufisq?!!
gile<?! Gmiiq?! Ogizgl<?! Ogizq?!
OgijpbXg<gq?! sic?! svl<?! Kutq?!
ligkq?! gje?! ost{<c?! k{<Mzq?!
g{l<?! gzqeq?! hi{l<?! hqh<hqzq?!
juOkgq?!nl<H?!NkqlVf<K/!
 
BOTANICAL NAME   : Piper longum 
            FAMILY                : Piperaceae 
            PART USED       : Dried unripe fruits 
            CHARACTERS: 
       Sju         :  -eqh<H    
        ke<jl         :   km<hl<   
        hqiqU!!!!!!!!!!!!!;!! -eqh<H 
         
ohiKg<G{l<;< << << <  
! -Vlz<!Ge<ll<!-jvh<H!gbh<hq{q!






! ! ohVf<!kqh<hqzqh<!Ohvr<Gjvg<gOu  





!!!!kqh<hqzqbiz<! -Vlz<?! Ge<ll<?! -jvh<H?! Jbh<hq{q?! =jt?! hi{<M<<< ?! lbg<gl<?!
Sjubqe<jl?! ohiVlz<?! kjzuzq?! &i<s<js! fQOvx<xl<?! oki{<jmOfib<?! &g<G! -!






                  
CHEMICAL CONSTITUENTS:   
   Volatile, Starch, Fatty oil, Piperine, piperttine, asarinine, pellitorine, 
piperlongumine, piperlonguminine, pipercide, piperderidine, resin, methylpiperine, 
certain amino acids.  
     Minerals such as calcium, phosphorus and Iron. 
   
8/!-zur<gh<hk<kqiq;< < << < << < < !
  SYNONYMS             :   kitqshk<kqiq?!klizhk<kqiq!
!!!!!!BOTANICAL NAME        :   cinnamomum tamala 
            FAMILY                           :    Lauraceae 
            PART USED                     :    Leaf 
            CHARACTERS: 
                 Sju                            :   gii<h<H!
                 ke<jl                         :   ouh<hl<!






!!!!!!!!!!!!!!!!!!!!!!!!.ngk<kqbi<!G{uigml</< < << < << < < !
G{l<;<<< !













    Methyl eugenol, eugenol, Trans cinnamyl acetate, beta- caryophyllene, tans-
cinnamyl acetate, ascabin, cinnamaldehyde. 
 Minerals such as calcium, magnesium, potasium, phosphorus, iron, zinc. 
Vitamins – Ascorbic acid, niacin and trace amount of riboflavin and folates. 
                              
9/!sqXfigh<H,;<<< !
            SYNONNYMS! ! ;!!!!!figl<?!figHm<hgl<?!fiOgsvl<?!Ogsvl<?!!
sil<Ohbl</!
    BOTANICAL NAME :           Mesua nagassarium 
  FAMILY   : Myristicaceae 
    PART USED              : Flower buds 
  CHARACTERS: 
             Sju              :    sqXjgh<H?!Kui<h<H!
!!!!!!!!! ke<jl              :   km<hl<!






!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!G{himl<!&zqjg!uGh<H< << << < !
G{l<;<<< !










CHEMICAL CONSTITUENTS:    
  linoleic,  oleic,  palmitic,  stearic acids,  xanthones,  coumartins,  biflavones, 
cyclohexanedione, phenolic coumarins, triterpenoids, fats, flavonoids, mesuol, 
mesuaxanthofle B, mammerisin, mesua ferrol, sitosterol, glycoside. 
 
:/!kitqshk<kq<<< Iq;!
  BOTANICAL NAME       :   Taxus buccata 
FAMILY    : Taxaceae 
PART USED            : Leaf 
            CHARACTERS: 
           Sju  :   giIh<H!
           ke<jl  : ouh<hl<!
















 CHEMICAL CONSTITUENTS: 
 Taxine,  essential oil,   Taxol, oxymethine, camphene, β- phellanolrene, 
deucosterol, campesterol, β-siosterol, resorcinol, myrcene, ligans, flavonoids, 
Terpinoids, phenols. 






21/!ogik<Klz<zq!uqjk;< << << < !
!!!!!!SYNONYMS!! !!! ;!!! dVt<!nVsq?!keqbi!!!!!!!!!
BOTANICAL NAME      :     coriandrum sataivum !
FAMILY         :    umbelliferae (apiaceae) 
 PART USED         : Seed 
            CHARACTERS: 
         Sju          :   gii<h<H!
        ke<jl           : sQkl<?!ouh<hl<!






!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!ngk<kqbi<!G{uigml</< < << < << < < !
G{l<;<<< !










 Essential oil – monoterpenoid,  linalool 
 Fatty oil – protein fat crude fibre and ash  
 Quercetin 3- glucuronide,   Isoquercitrin,  Rutin  
  Anti oxidant compounds β-carotene β- cryptoxanthin epoxide, lutein-5,6-
epoxide, violaxanthin, neoxanthin, socoumarines, coriandrones A,B,C,D, and E, 
isocoumarins, coriandrin, dihydrocoriandrin. 
 Minerals such as calcium, phosphorus, sodium, magnesium, zinc, potasium, 




22/!ofz<zqLt<tq;!< << << < !
!!!!! SYNONYMS           :  Nlzgl<?!Nzgl<?!Nl<hz<?!Nliqgl<?!!
kik<kiiq?!kik<kqiq?!Ogivr<gl<?!!
lqVKhzi?!lQKf<K/!
!!!!!BOTANICAL NAME            :         phyllanthus emblica  
            FAMILY                               :        Euphorbiaceae 
            PARTS USED                      :         Dried Fruit 
            CHARACTERS: 

















!!!! fiUg<Gs<! Sjujbk<! kVgqe<x! ofz<zqLt<tqbiz<! dm<$M?! wZl<HVg<gq!
Ofib<?! GVkqbpz<! Ofib<?! ohVl<hiM?! ouxq! Ofib<?! fQvVgz<?! uif<kq?! out<jt?!
N{<Gxqg<!ogih<htl<!Ngqb!-jugt<!uqzGl</!






  Vitamin C,  Tannin,  Emblicanin A, Emblicanin B, Tannins such as 
punigluconin, 2-keto-gluconolactone, ellagic acid, hexahydroxy-diphenic acid, 
pedunclagin, amino acids,  glutamic acids, proline, aspartic acid, alanine, lysine. 
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23/!sikqg<gib<< << << < 
! SYNONYMS!! !!!! ;! Gzg<gib<?!\ikqg<gib<!
! BOTANICAL NAME       : Myristica fragrans 
 FAMILY                           : Myristicaceae 
 PART USED         : Seed 
            CHARACTERS: 
       Sju         :      Kui<h<H!
       ke<jl         : ouh<hl<!







! ! ! ! ! ! .!G{himl<!Lzqjg!uGh<H< << << < !
!
G{l<<<<: 
! uqf<K! GjxU?! ohVr<gpqs<sz<?! uiBuqeiZ{<miGl<! Ofib<?! kjzuzq?!












 Myristic acid,  myristicol Saponin, Myristicin – Terpenoid.    Essential Oil, 
Sabinene,  -pinene, Terpinene , elemicin, safrole, trimyrishtin, myrcene. 
 Minerals such as iron, magnesium, manganese, lead, chromium, nickle. 





  SYNONYMS               :  Ns<sikfhjz?!hiq?!dk<kqiq?!
gix<hisl<?!he<ez</!
!!!!! BOTANICAL NAME    :!     Gossypium herbaceum     
         FAMILY                         :       Malvaceae  
         PARTS USED                 :       Seed 
         CHARACTERS: 
         Sju!!!!!!!!!!!!;!!!! Kui<h<H?!-eqh<H!
!!!! ! ke<jl!!!!!!!!!!!;!!!! ouh<hl<!












CHEMICAL CONSTITUENTS:  
               Betaine, choline, salicyclic acid, querdetin, saponins, carbohydrates, 
proteins, glycosides, steroids, resins, phenolic compounds tannins, enzymes such as 
lipase, catalase, peroxidase, phytase. 
Minerals such as iron, sodium , manganese and zinc. Vitamin A, D, E and B 
COMPLEX.        
    
 14. oum<cOui<< << << <!;!
  SYNONYMS                      :    GVOui<!
!!!!!!BOTANICAL NAME         :   Vetteveria zizanioidus 
            FAMILY                              :    Poaceae 
            PART USED                        :    Root  













!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!hkii<k<k!G{sqf<kil{q< < << < << < < !
G{l<;<<< !
!! hqk<kk<kiz<! ngizk<kqz<! d{<migqe<x! kigl<?! ssq?! OsilOvigl<?! gilqzl<?!
gilijz?! gjxh<hqk<kl<?! vk<k! hqk<kl<?! nez<Svl<?! G]<ml<?! kjzOfib<?! gt<lc?!
gPk<KOfib<?! Sg<gqzf]<ml<?! lf<kl<?! de<likl<?! nez<H{?<! kQh<H{<?! keh<H{<?!










              α and β vetivone, zizanal, epizizizanal, 9-octadecenamide, hexamethyl, 22-
tetracosahexaene, 1,2-benzendicarboxylic acid, diisooctyl ester, terpinoids, 
sesquiterpenes. 
!
26/!uqzilqs<S!Oui<;< << << < !!
  SYNONYMS                  :    GXOui,<!-VOuzq!
    BOTANICAL NAME     :    Coleus vettiveroides 
      FAMILY                          :     Lamiaceae 
           PART USED                   :     Root 
     CHARACTERS: 











!!!! ! ! ! ! !.!G{himl<!&zqjg!uGh<H< << << < !
G{l<;<<< !








  Androstan-17-one 3-ethyl-3-hydroxy-(5α), spathulenol,  α-bisabolol, Z-
valerenyl  acetate, megastigma4,6(E), 8(Z)-triene, 1H-cycloprop(E)azulen-7-ol, 
decahydro-1,1,7-trimethy l-4-methylene, myrtenol,, 1-naphthalenol, 
caryophylleneoxide,  abieta, a salt of lime and oxide of iron. 




!!!! SYNONYMS                  :    Okijv?!ju?!uqiqgq?!osf<ofz<?!sizq?!uiq/!
        BOTANICAL NAME       :   Oryza sativa 
       FAMILY                           :    Poaceae 
    PART  USED                   :     Roasted seed 
             CHARACTERS: 

























            Isoleucine, leucine, lysine, phenylalanine, tyrosine, total sulphur amino acids, 
methionine, threonine, tryptophan, valine, carbohydrates. 
 Minerals such as zinc, iron.  Vitamin - A 
 17. wZlqs<js;<<< !
!!!!!!! SYNONYMS                   :    sl<hqvl<?!skigeq!
             BOTANICAL NAME         :    Citrus limon 
             FAMILY                             :    Rutaceae 
             PART USED                      :    Fruit 
             CHARACTERS: 
                !!! ! Sju!!!!!!!!!!!!;!! Htqh<H!
!!!!!!!!!! ! ke<jl!!!!!!!!!!!;!! ouh<hl<!






!!!!!!!!!!!!!!!!!!!!!!!! ! .!ngk<kqbi<!G{uigml</< < << < << < < !
G{l<;<<< !






                 Gtqi<s<sqB{<mig<gq!
CHEMICAL CONSTITUENTS: 
  Limonene, β- pinene, α- citral, α- terpinene, monoterpens, linalool, geraniol, 
linalyl acetate, geranyl acetate, cis-ocimene 
             A pale yellow volatile oil derived on either by distillation or by simple 
expression from the fresh outer part of the pericarp. Citric acid available in lemon 
juice. 
 Vitamin – C, B6.  Mineral – Potasium. 
 
18.  -R<sq!siX;<<< !
!!!!!SYNONYMS         :    nz<zl<?!Ni<k<kvgl<?!Nk<kqvgl<?!!
-zig<ogim<jm?!fXlVh<H!lkqz</!
           BOTANICAL NAME         :    zingiber officinalae 
           FAMILY                             :    zingiberaceae 
           PART USED                      :    Rhizome 
           CHARACTERS 
                !!! ! Sju!!!!!! ;!! gii<h<H!
!!!!!!!!!! ! ke<jl!!!!!!;!! ouh<hl<!






!!!!!!!!!!!!!!!!!!!!!!!!!!!!!.!ngk<kqbi<!G{uigml< << << < </!
G{l<;<<< !
!! -R<sqbqeiz<! -Vlz<?! =jt?! out<Otig<gitl<?! npz<Gx<xl<?! utq$jz?!












  Gingerols shogalos, sesquiterpenes, β-bisabolene, (-)-zingiberene, zingiberene, 
zingiberol, curcumene, monoterpenses, geranial, neral. 
!
2:/!hje!ouz<zl<;< << << < !
!!!!! SYNONYMS                 :    kizl<?!gVl<Hxl<?!Wmgl<?!gill<?!!
kVuqvige<?!kitq/!
       BOTANICAL NAME :   Borassus flabellifer 
      FAMILY                       :   Arecaceae 
       ENGLISH NAME         :   Palm jaggery 
       CAHRACTERS: 
                Sju!!!!!!!!!! ;!! -eqh<H!
!!!!!!!! ke<jl!!!!!!!!! ;!! km<hl<!!



















KINGDOM  : Animalia 
            SPECIES      :  Apis Mellifera 
            FAMILY      :  Apidae 






 hsqk<kQK~{<c                                             
                                                        -G{himl<!kiK!\Qu!uGh<H< Q << Q << Q < !
CHEMICAL CONSTITUENTS: 
     Organic and amino acid, formic, acetic, butyric, citric, lactic, malic, 
pyroglutamic, propionic, valeric, capronic, palmitic, succinic, pantothenic acid, 
vitamin B6, folic acid. 
                  Minerals such as iron, zinc, potassium, phosphorus, calcium. 





Fig no.2  INGREDIENTS OF SIRU VILVATHI ELAGAM 
 
 





















ogik<Klz<zquqjk< << << < !
(Coriandrum sativum ) 
ofz<zqLt<tq< << << < !
(Phyllanthus emblica) 







oum<cOui<< << << <!
(Vetiveria zizanioides) 













Fig. No. 3   SIRU VILVATHI ELAGAM 




6. BIO-CHEMICAL ANALYSIS OF SIRU VILVATHI ELAGAM 
 
Preparation of the extract:  
 5gms of the drug was weighed accurately and placed in a 250ml clean beaker 
then 50ml of distilled water is added and dissolved well. Then it is boiled well for 
about 10 minutes. It is cooled and filtered in a 100ml volumetric flask and then it is 
making up to 100ml with distilled water.  This fluid is taken for analysis. 
 
Table no.1 QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution 





2. TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
A white precipitate is 
formed 
Indicates the 
Presence  of 
Sulphate 
3.  TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution 




4. TEST FOR CARBONATE 







5. TEST FOR STARCH 
The extract is added with weak iodine 
solution 
No Blue colour is 
formed 
Absence  of 
Starch 
6.  TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro cyanide. 
No blue colour is 
formed 
Absence of ferric 
Iron 
7. TEST FOR FERROUS IRON  
The extract is treated with concentrated 
Nitric acid and Ammonium thiocyanate 
solution 







8.  TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow 
precipitate is formed 
Absence of 
Phosphate 
9.  TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No yellow 
precipitate is formed 
Absence of 
Albumin 
10.  TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
No Blue black 
precipitate is formed 
Absence of 
Tannic acid 
11.  TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets decolourised 
Indicates the 
presence of  
Unsaturated 
compound 
12.  TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 minutes and add 8-10 drops of the 
extract and again boil it for 2 minutes. 
No Colour change 
occurs 
Absence  of  
Reducing sugar 
13.  TEST FOR AMINO ACID 
One or two drops of the extract is placed 
on a filter paper and dried well. After 
drying, 1% Ninhydrin is sprayed over the 
same and dried it well. 
Violet colour is 
formed 
Indicates the 
Presence of  
Amino acid 
14. TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white precipitate 
is formed 
Absence of Zinc 
 
Inference: 
 The given sample of “SIRU VILVATHI ELAGAM” contains Calcium, 




7. PHARMACOLOGICAL ANALYSIS 
HAEMATINIC ACTIVITY OF SIDDHA FORMULATION  
SIRU VILVATHI ELAGAM  
IN PHENYLHYDRAZINE INDUCED ANAEMIC RATS 
 
INTRODUCTION 
  Iron is the main component of haemoglobin which is responsible for 
transporting oxygen, which in turn help in proper functioning of part of many 
enzymes which are involved in cellular processes, respiration and cell division. 
Anaemia is defined as the reduction of haemoglobin below the normal limit and is 
the most common disorder of the blood. Recently, the World Health Organization 
(WHO) estimated that anaemia affects one-quarter of the world's population and is 
concentrated within preschool age children and women. Iron deficiency affects a 
significant part, and often a majority, of the population in nearly every country in the 
world. Iron deficiency is estimated to be the most   common   cause   of   anaemia   
worldwide   and   is particularly prevalent in developing nations in Africa and Asia. 
Prevalence of anaemia all age group is higher in India as compared to other  
developing countries. It has serious consequences for the health and well-being as 
well as social and economic impacts of India. Untreated iron deficiency anaemia can 
become severe enough to interfere with daily life. From the above discussions, it is 
very clear that we are in a critical need to control anaemia. In this connection, a 
search for cheap, easily available and efficacious haematinic drugs in the modern 
world is going on. Drugs from the plant material are generally believed to be more 
effective and having fewer side effects compared to modern synthetic medicines. 
Knowledge of iron deficiency and its treatment in Siddha System of medicine dates 
back from time immortal. Many plants in Siddha system of medicine are known  to  
have remarkable effects in treating anaemia. Hence a comprehensive literature search 
was performed in siddha texts. A classical siddha formulation Siru Vilvathi Elagam was 
indicated for 40 types of pitha diseases, Indigestion, nausea, ageusia, anemia, jaundice 
in Anuboga Vaithiya Navaneetham (part-8)  Hence in this study, we propose to study 
the haematinic activity of the trial Siru Vilvathi Elagam   in phenylhydrazine induced 






          Wistar rats of both the sex was used in this study, Animals were 
maintained with 12 hours dark and 12 hour light cycle with free access to 
standard rat feed and water. 
Anaemia model:  
           24 animals aged between 6-8 weeks were divided in to 4 groups with 6 animals 
in each group. Animals of Group I received normal saline 5ml/kg. Group II animals 
were treated with Phenyl hydrazine (PHZ) 40mg/kg (i.p) for two days (Day1 and 
Day2) and served as disease control. Animals of group III received PHZ injection 
40mg/kg (i.p) and treated with 200 mg/kg SVE  from 3rd to 16th Day. Whereas 
animal belongs to group IV treated with 400 mg/kg SVE from 3rd to 16th Day and 
served as Treatment group. 
Blood Collection 
            Animals were sacrificed at the end of the study and blood samples were 
collected from Retro-Orbital Sinus puncture and stored in EDTA (ethylenediamine - 
tetra acetate) test tubes for Haematological analysis. Analysis was performed using 
Mindray BC 2800 Haematology Analyse.  
Bio-chemical Parameter    
At the end of the study blood will be collected by ocular puncture after 
overnight fasting animals. The blood parameters such as Red Blood Cell Count 
(RBC), White Blood Cell Count (WBC), 
Haemoglobin Concentration (Hb) and Haematocrit was determined using 
Mindray BC 2800 Haematology Analyzer . 
Statistical analysis 
            Results are presented as the average ± Standard deviation and the differences 
among test groups were assessed by one- way analysis of variance followed by 
Dunnett’s multiple comparison test using  Grapad prism 5.0 software (Graph pad, La 





          Table no.2 Haematology Profile of Phenyl hydrazine induced anaemic rats 




















I II III IV
RBC (×10 6µl)




RBC WBC HGB 
HCT (%) (×10 6µl) (×10 3 µl) (g/dl) 
I Normal saline 
(5ml/kg) 
8.92 ± 0.20 8.90±0.76 11.09±0.9 33 ±0.20 
     
II Phenylhydrazine (PHZ) 
40 mg / kg , i.p 
5.02±0.03 6.50±0.16 8.02±0.1 24±0.19 
     
III PHZ+ SVE 200mg/kg, p.o 6.01± 2.01 7.01±0.2 9.01±0.2 30.09±0.9 
IV PHZ+ SVE 400mg/kg, p.o 6.09±2.1 7.01±0.2 10.29±0.2 32.02±0.2 







               












Normal saline (5ml/kg) 
 






































































EFFECT OF SIRU VILVATHI ELAGAM  ON HAEMATOLOGY PROFILE OF 
PHENYL HYDRAZINE INDUCED ANAEMIC RATS 
 
  The Mean Haemoglobin (Hb) content (g/dl) was significantly decreased in 
disease Control compared with control. This signifies that anaemia was successfully 
induced in all the animals. There was significant increase in Hb content of animals 
treated with 200 and 400mg/kg of SVE compared with control. This observation 
reflects the promising haematinic property of the trial drug SVE in treated rats. 
             There was a significant decrease in the level of RBC in animals of group II 
5.02±0.03when compare to that of the normal control  with 8.02±0.20 Treatment with 
SVE at both the dose level shown marked increase in RBC level with 6.01± 2.01for 
SVE 200mg /kg and 6.09±2.1for SE 400mg/kg. Similar results were observed with 
respect to WBC count. 
            The Haematocrit (HCT) test indicates the percentage of blood by volume that 
is composed of red blood cells. Treatment with PHZ shown significant decrease in 
HCT with the level of 24±0.19 lower when compares to control rats. Animals treated 
with 200 and 400mg/kg of SVE has shown increased HCT value.  
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EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF  
SIRU VILVATHI ELAGAM 
 
  In traditional medicines, various herbal preparations are being used for 
treating liver disorders. In the absence of an effective treatment in modern medicine, 
efforts are being made to find out suitable herbal drugs. The present study was taken 
up to evaluate the effects of SIRU VILVATHI ELAGAM against Isoniazid and 
Rifampicin induced hepatotoxicity.    
 
Materials and methods:- 
  The protocol was approved by the institute’s animal ethical committee. 
 
Animals and treatment: 
  Male wistar rats, aged 6-8 weeks between 180-200 g body weight were used in 
the study. Animals were housed in air conditioned rooms with exposure to 12h light – 
dark cycle. They were provided with standard rat feed with free access to food.   
  For hepatotoxicity model, 100 mg/kg per day of Isoniazid (INH) and 
Rifampicin (RIF) each was used in the study (4) INH and RIF solution were dissolved 
separately in sterile distilled water. Rats were treated with INH, co-administered with 
RIF for 21 days. For the hepatoprotective model, 200 mg/kg per day of   
SIRU VILVATHI ELAGAM extract and 400 mg/kg SIRU VILVATHI ELAGAM 
extract along with INH+RIF solution was administered. 
 
Treatment protocol: 
Group I :  Normal control the animals were given  
normal saline only. 
Group II : Hepatotoxicity control the animals were given  
INH+RIF for 21 Days. 
Group III :  Standard group the animals were given 
     INH+RIF+SILYMARIN  orally for 21 days. 
Group IV :  Treatment group the animals were given  
INH+RIF+SVE  (200 mg/kg orally for 21 days). 
Group V :  Treatment group the animals were given INH+RIF+  






  Rats were treated as per the above protocol. In the present study 
hepatoprotective activity was evaluated biochemically and histopathologically. On 
day 21 the rats were anaesthetized and sacrificed 1 hr after drug administration. The 
blood was collected by retro-orbital plexus method and serum was separated by 
centrifugation and various liver function  parameters such as alkaline phosphatase 
(ALP), AST (S.G.O.T), ALT (S.G.P.T), cholesterol, total protein and Albumin were 
analysed. 
  The liver was carefully isolated and weight of each liver was recorded. Then it 
is preserved for histopathological analysis. 
 



















































































































G4-Treatment Control, SVE (200mg/kg) 
G5-Treatment Control, SVE (400mg/kg) 
 
**a-values are significantly different from control (G1) (P<0.001), 
**b-values are significantly different from toxic control (G2) P<0.001 
All values are found out by using one way ANOVA followed by Newman Keul’s 


























Normal control (G1): 
       Histopathological observation of liver section from normal control group (G1) 
shows normal cellular architecture with distinct hepatic cells, sinusoidal spaces and a 
central vein. 
Toxic control (G2): 
        INH, Rifampicin in toxicated group animal (G2) showed total loss of hepatic 
architecture with centrilobular hepatic necrosis and fatty changes. 
Silymarin treated group (G3): 
        Silymarin treated group (G3) had normal liver architecture and occasional 
inflammatory cells with no traditis or necrosis. 
Treatments (G4): 
     Histopathological pattern of the liver of rats treated with INH, Rifampicin & lower 
dose of SVE showed minimal necrosis, mild inflammation & less steatosis. 
Treatment (G5): 
     Pre-treatment with higher dose of SVE shows mild inflammation and complete 
regeneration of hepatocytes & lobular architecture. 
 
CONCLUSION: 
  In the present study, SVE exhibit strong hepatoprotective activity, afforded 
protection from INH,  induced liver damage. Hepatoprotective activity of extract of 
siru vilvathi elagam may be due to free radical scavenging activity due to presence 
of Flavonoids and antioxidants. Additional studies are needed to better understand the 












Figure No: 4 
Normal Control  
 
 
(Section of liver parenchyma with hepatocyte which appears normal and central vein & portal 
tract are normal.) 










Figure No: 6 
Positive Control 
 
 (Section of liver parenchyma shows normal hepatic architecture) 
Figure No: 7 
Treatment group (4)  - Low dose 
                









Figure No: 8 
Treatment group (5)  - High dose 
 
 
(Section of liver parenchyma with hepatocyte which appears normal and central vein & portal 
tract are normal.) 
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EVALUATION OF ACUTE TOXICITY STUDY (14 Days) OF  
SIRU VILVATHI ELAGAM 





No. of animal affected. 
Group-I 5mg/kg Normal 0 of 3 
Group- II 50mg/kg Normal 0 of 3 
Group-III 300mg/kg Normal 0 of 3 
Group-IV 1000mg/kg Normal 0 of 3 
Group-V 2000mg/kg Normal 0 of 3 
 

































Body position Normal 3 3 3 3 3 








Normal 3 3 3 3 3 
Palpebral 
closure Normal 3 3 3 3 3 
Approach 
response Normal 3 3 3 3 3 
Touch 
response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response Normal 3 3 3 3 3 
101 
 


































Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral 
closure Normal 3 3 3 3 3 3 
Lacrimation Normal 3 3 3 3 3 3 
Salivation Normal 3 3 3 3 3 3 
Piloerection Normal 3 3 3 3 3 3 
Pupillary 
reflex Normal 3 3 3 3 3 3 
Abdominal 
tone Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
 
Table no.8   Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I 5(mg/kg) 0 of 3 
Group-II 50(mg/kg) 0 of 3 
Group-III 300(mg/kg) 0 of 3 
Group-IV 1000(mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
RESULT: 
  From acute toxicity study it was observed that the administration of               
SIRU VILVATHI ELAGAM at a dose of 2000 mg/kg to the rats do not produce 
drug-related toxicity and mortality. So No-Observed-Adverse-Effect- Level 





  SIRU VILVATHI ELAGAM was administered single time at the dose of 
5mg/kg, 50mg/kg,  300mg/kg, 1000mg/kg and 2000mg/kg to rats and observed for 
consecutive 14 days after administration. Doses were selected based on the pilot 
study and literature review. All animals were observed daily once for any abnormal 
clinical signs. Weekly body weight and food consumption were recorded. No 
mortality was observed during the entire period of the study. Data obtained in this 
study indicated no significance physical and behavioural signs of any toxicity due 
to administration of SIRU VILVATHI ELAGAM at the doses of 5mg/kg, 50mg/kg 
, 300mg/kg, 1000mg/kg and 2000mg/kg to rats.  
  At the 14th day, all animals were observed for functional and behavioural 
examination. In functional and behavioural examination, home cage activity, hand 
held activity were observed. Home cage activities like Body position, Respiration, 
Clonic involuntary movement, Tonic involuntary movement, Palpebral closure, 
Approach response, Touch response, Pinna reflex, Sound responses, Tail pinch 
response were observed. Handheld activities like Reactivity, Handling, Palpebral 
closure, Lacrimation, Salivation, Piloercetion, Papillary reflex, abdominal tone, 
Limb tone were observed. Functional and behavioural examination was normal in 
all treated groups. Food consumption of all treated animals was found normal as 
compared to normal group. 
  Body weight at weekly interval was measured to find out the effect of  
SIRU VILVATHI ELAGAM on the growth rate. Body weight change in drug 





SUB-ACUTE TOXICITY STUDY IN WISTAR RATS TO EVALUATE 
TOXICITY PROFILE OF SIRU VILVATHI ELAGAM 
 
Table no.9 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF SIRU 
VILVATHI ELAGAM ON BODY WEIGHT IN GRAM 
GROUP CONTROL LOW MID HIGH 
1st day 118.3±1.03 121±1.543 120.3±2.231 122.3±2.23 
7th day 128.3±1.03 127.3±1.343 127±2.113 133±2.11 
14th day 130.1±1.004 132.3±1.12 132.4±2.012 134.4±2.012 
21st day 135.3±2.120 136.2±1.501 136±1.131 136.5±1.13 
28th day 140.3±1.041 140.3±1.202 140.4±2.0405 142±2.040 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 




















EFFECT OF SUBACUTE DOSE (28 DAYS) OF SIRU VILVATHI ELAGAM 
Table no.10 SIRU VILVATHI ELAGAM ON ORGAN WEIGHT  
(PHYSICAL PARAMETER) IN GRAM 
 
GROUP CONTROL LOW MID HIGH 
HEART 2.39±0.02 2.40±0.04 2.43±0.11 2.44 ±0.02 
LIVER 8.27± 0.23 8.29±0.23 8.16±0.01 8.18± 0.23 
LUNGS 4.27±0.10 4.27±0.14 4.30±0.24 4.33±0.10 
KIDNEY L 1.39±0.02 1.39±0.03 1.40±0.02 1.41±0.02 
 R 1.37±0.024 1.40±0.02 1.41±0.024 1.42±0.024 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
























EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF SIRU VILVATHI ELAGAM 
ON HAEMATOLOGICAL PARAMETERS 











bin gm % 






















































Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by Dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
































































































Table no.12  EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF                                      














Control 38.14±3.02 38.24±4.31 239.12±11.32 31.35±3.00 0.80±0.03 
LOW 38.13±3.22 37.23±4.01 247.11±12.42 36.53±2.42 0.46±0.04 
MID 37.21±4.44 37.31±2.21 241.45±4.14 35.12±2.22 0.61±0.04 










































































0.908±0.57 0.958±0.2827 0.819±0.3376 0.704±0.199 
  
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 














Table no. 14 EFFECT OF SUB- ACUTE DOSE (28 DAYS) OF  
SIRU VILVATHI ELAGAM ON FOOD INTAKE IN GRAM 
 
GROUP CONTROL Low mid High 
1st DAY 12.33±13.5110 15.1672±14.3 8.10±21.71 13.5±7.62 
7th DAY 11.5±11. 11.863±12.67 12.73±9.853 11.17±14.41 
14th DAY 14.83±8.72 11.83±14.28 11±13.96 15.72±8.981 
21st DAY 14.87±12.4 11.04±8.466 11.88±9.43 15.17±8.02 
28th DAY 14.10±11.38 14.38±11.50 14.06±8.90 14.36±7.57 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 























Table no. 15 Effect of Sub- Acute Dose (28 Days) of SIRU VILVATHI 
ELAGAM on Water Intake in ml 





1st DAY 98.3338±13.5110 89.1672±14.3426 102.10±21.7199 67.5±7.6203 
7th DAY 85.5±11.7938 100.863±12.6770 76.6673±9.85363 81.6717±14.4150 
14th 
DAY 
58.3383±8.72817 90.8363±14.2812 80±13.9692 89.1672±8.88981 
21st DAY 91.6687±12.4949 85±8.46662 65.8338±9.43550 89.1717±8.79602 
28th 
DAY 
82.10±11.3840 88.3348±11.5004 80±8.90061 80±7.57773 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-
way ANOVA followed by Dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group 
 
 
Table no.16 EFFECT OF SUB ACUTE DOSES (28 DAY) OF SIRU 
VILVATHI ELAGAM ON ELECTROLYTES 
 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one-









Sodium (mg/dl) 123.10±0.6855 134.30±0.6792 135±0.7571 135.80±0.70 
Calcium(mg/dl) 17.580±0.137889 10.20±0.175783*** 13.7±0.165299*** 16.180±0.19611*** 
Phosphorus 
(U/L) 












































  All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
Mortality: 
  All animals in control and in all the treated dose groups survived 
throughout the dosing period of 28 days. 
Body weight: 
  Results of body weight determination of animals from control and different 
dose groups exhibited comparable body weight gain throughout the dosing period 
of 28 days. 
Food consumption: 
  During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with 
that by control animals. 
Organ Weight: 
  Group Mean Relative Organ Weights (% of body weight) are recorded. 
Comparison of organ weights of treated animals with respective control animals on 
day 29 was found to be comparable similarly. 
Hematological investigations: 
  The results of hematological investigations conducted on day 29 revealed 
following significant changes in the values of different parameters investigated 
when compared with those of respective controls; however, the increase or 
decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
Biochemical Investigations: 
  Results of Biochemical investigations conducted on the day 29th were 
recorded and revealed the following significant changes in the values of hepatic 
serum enzymes studied. When compared with those of respective control. 
However, the increase or decrease in the values obtained was within normal 





1) All the animals from control and all the treated dose groups up to 
2000mg/kg survived throughout the dosing period of 28 days. 
2) No signs of toxicity were observed in animals from different dose groups 
during the dosing period of 28 days. 
3) Animals from all the treated dose groups exhibited comparable body weight 
gain with that of controls throughout the dosing period of 28 days. 
4) Food consumption of control and treated animals was found to be 
comparable throughout the dosing period of 28 days 
5) Haematological analysis conducted at the end of the dosing period on day 
29th, revealed no abnormalities attributable to the treatment. 
6) Biochemical analysis conducted at the end of the dosing period on day 29th, 
no abnormalities attributable to the treatment. 
7) Organ weight data of animals sacrificed at the end of the dosing period was 





8. ANTIMICROBIAL STUDIES 
Aim 
 To study the Anti-microbial action of “Siru Vilvathi Elagam” against  
Escherichia Coli and Pseudomonas aeruginosa 
Medium 
Mueller Hinton agar. 
Components of medium  
Beef extract   - 300gms/lit 
Agar    - 17 gms/lit 
Starch    - 1.5 gms/lit 
Casein Hydroxylate  - 17.5 gms/lit 
Distilled water  - 1000 ml 
PH    - 7.6 
Procedure 
 The media was prepared from the above components and poured and 
dried on a petri dish. The organism was streaked on the medium and the test 
drug (1gm drug in 10ml of water) was placed on the medium. This is incubated 
at 37°C for one over night and observed for the susceptibility shown up 
clearance around the drug. 
Result: 
  The test drug Siru Vilvathi Elagam was sensitive against 



















9. OBSERVATIONS AND RESULTS 
  For this clinical study 40 cases were selected, 20 cases were treated  in           
IN PATIENT ward and 20 cases were treated in OUT-PATIENT ward of Post 
graduate Department of Kuzhanthai Maruthuvam, Government  Siddha Medical 
College and Hospital, Palayamkottai. 





4. Family  History 
5. Socio economic status 
6. Diet 
7. ParuvaKaalam 
8. Mukkutra Kaalam 
9. Thinai 
10. Aetiological factors 
11. Mukkutra nilai 
12. Ezhu Udal Kattukal 
13. Envagai thervukal 
14. Neikuri 
15. Clinical presentation 
16. Signs and symptoms of MANNUN VELUPPU NOI  during admission and 
discharge  
17. Haematological profile 
18. Outpatient recored  
19. Results after treatment 
 The observations recorded with the above said criteria were given in the 
tabular column form 
 





Table no.1  Distribution  of Patients According to age 
S.No Age Paruvam No of  Cases Percentage 
1. 0.6 Month   Kappu Paruvam  - - 
2 6-12 Month  Kappu and Senkeerai Paruvam - - 
3 1-2 year  Thalattu,  Sappani, Mutham  and  
varugai Paruvams  
- - 
4 3-6 years  Ampuli,  Sitril, Siruparai Siruthaer 
Viduthal (Male Child) Ammanai, 
Neeraduthal,  oonjal (Female 







5 6-12 Years Siruparuvam (Male Child)  






   
 
Inference 
  Among 40 patients treated 55% of cases belongs to 3-6 years and 













































































































































































Table no.2 Distribution  According to the Sex 
 
S.No Sex No. of  Cases Percentage 
1. Male Children   17 42 






Out of  40 cases selected 42% of  Patients were male children and 58% 
































Table no.3  Distribution According to the Religion 
 
S.No Religion No.of  Cases Percentage 
1. Hindu  26 65 
2. Christian   4 10 
3. Muslim  10 25 
 
   
 
   
Inference 
Out  of 40 cases 65% of the people  were Hindus   10% were Christians  





























S.No Family  History 
1. Positive  
2. Negative  
 
   
 
Inference 






  Distribution According  to Family  History

















Table no.5  Distribution of Patients According to the  
Socio Economic Status 
 
S.No Economic Status No.of  Cases Percentage 
1. Poor  26 65 
2. Middle  14 35 






Out of 40 Patients, 65% of people belongs to poor family and 35%  of  





























Table no.6   Distribution According to Dietary Habits 
 
S.No Economic Status No.of  Cases Percentage 
1. Vegetarian  8 20 
2. Mixed  32 80 
  




Out of 40 cases, 80% of cases  have mixed diet and 20% of cases have 



























Table no.7  Distribution of  Patients  According  To Paruva Kaalam 
 
S.No Paravakaalam No.of Cases Percentage 
1. Kaar (Aavani,  Paratasi)   7 17.5 
2. Koothir (Iypasi, Karthigai)  4 10 
3. Munpani (Margali,  Thai)  12 30 
4. Pinpani (Masi, Pankuni) 10 25 
5. Elavenil (Chithirai, Vaikasi)   - - 





According to paruva kaalam  17.5% of Cases were admitted in  Kaar  
Kaalam,  10%  of  Cases were admitted in Koothir kalam and 30% of Cases 
were admitted in Munpani kaalam, 25% of cases were admitted in Pinpani 























Table no.8  Distribution According to the Mukkutra Kalam 
S.No Kaalam No.of Cases Percentage 
1. Vatham  40 100 
2. Pitham  - - 




 In this study all the 40 patients were in Vatha kaalam,  Since all the 














Vatham Pitham Kapham 
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Table no.9  Distribution According to thinai 
S.No Thinai No.of cases Percentage 
1. Kurinji (Hill area)          1 2.5 
2. Mullai (Forest area) - - 
3. Marutham (Fertile area) 39 97.5 
4. Neithal (Coastal area) - - 
















































Table no.10  Distribution According to the Aetiological Factors 
 
S.No Aetiological Factors No.of cases Percentage 
1. Iron Deficiency 36 90 
2. Worm infestation 4 10 
 




Out of 40 cases selected major cause of the disease is Iron deficiency i.e 




























Table no.11 Distribution According to the Mukkutra Nilai. 
A.Affected Vatham. 
S.No Vatham No.of cases Percentage 
1. Pranan 23 57.5 
2. Abaanan 12 30 
3. Viyaanan 40 100 
4. Uthaanan - - 
5. Samaanan 40 100 
6. Naagan - - 
7. Koorman - - 
8. Kirukaran 40 100 
9. Devathathan 40 100 
10. Thananjeyan - - 




Among 10 types of vatham Viyaanan, Samaanan, Kirukaran and 
devathathan were affected in all 40 cases Pranan were affected in 57.5% and 




























































































B. Affected Pitham 
S.No Pitham No.of cases Percentage 
1. Anar pitham 40 100 
2. Ranjagam 40 100 
3. Prasagam 40 100 
4. Sathagam 40 100 
5. Alosagam - - 
 
   
 
Inference 
 Among 5 types of pitham anarpitham, ranjagapitham, sathagapitham, 
prasagapitham were affected in 40 cases. 
  













Anar pitham Ranjagam Prasagam Sathagam Alosagam
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C. Affected Kabam 
S.No Kabam No.of cases Percentage 
1. Avalambagam 40 100 
2. Kilethagam 40 100 
3. Pothagam 40 100 
4. Tharapagam - - 






 Among 5 types of kabam avalambagam, kilethagam and pothagam were 




























Table no.12  Distribution According to Ezhu Udal Kattukal. 
 
S.No Udal kattugal No.of cases Percentage 
1. Saaram 40 100 
2. Senneer 40 100 
3. Oon - - 
4. Kozhuppu - - 
5. Enbu - - 
6. Moolai - - 







































































Table no.13  Distribution According To Envagai  Thervukal 
SI.NO En vagai Thervugal No.of cases Percentage 
1. Naa 40 100 
2. Niram 28 70 
3. Mozhi - - 
4. Vizhi 40 100 
5. Malam 13 32.5 
6. Moothiram 24 60 
7. Naadi 
    Vathapitham 
    vathakabam 
    Pithavatham 
    Pithakabam 


















 Among the envagai thervugal, Naa, Vizhi were affected in all the cases 
100%, Niram affected in 70% of cases, Malam affected in 32.5% of cases, 






























Inference                                
 Among  9 types of nadi Vathapitham were observed in 35% of cases, 
Vathakabam were observed in 15% of cases, Pithavatham were observed in 
35% of cases, Pithakabam were observed in 12.5% of cases, Kabapitham were 






















Table no.14  NEIKURI 
S.No               Neikuri  Number of cases           Percentage 
 1. Vatha Neer  
(Spreads like serpent) 
          20      50 
 2. Pitha Neer (Spreads like ring)            15      37.5 




 Out of 40 cases, Vatha neer were observed in 50% of cases, Pithaneer 






















Table no.15 Distribution According To The Clinical Presentation 







1. Habit of pica 40 6 
2. Pallor of conjunctiva, nail beds 
and  tongue 
40 5 
3. Anorexia 40 7 
4. Ulceration of mouth 12 2 
5. Constipation 13 5 
6. Lassitude 40 3 
7. Emaciation 7 1 
8. Palpitation 16 4 
9. Dyspnoea on exertion 8 3 




















Unrecovered Symptoms in subjects
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Table no.16 IN PATENTS WARD – CASE SHEET 
Sl. No. IP. No. Name of Patient 
Age / 







1.  1671 Mathavi 8/FC Habit of pica, Pallor of conjunctiva and nail beds, Tiredness, Anorexia, lassitude,  Palpitation, headache. 28.06.2018 25.07.2018 28 Good 
2.  2452 Rajeswari 10/FC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, constipation, Hair fall, Spoon shaped 
nails (koilonychia), Anal itching, fecus with worm. 
28.09.2018 24.10.2018 27 Good 
3.  3181 Samuvel 9/MC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, dyspnoea on exertion, palpitation, 
dizziness 
28.12.2018 24.01.2019 28 Good 
4.  15 Senthamil selvi 5/FC Habit of pica, Pallor of conjunctiva nail beds and tongue, Anorexia, lassitude, Emaciation, Hair fall 03.01.2019 24.01.2019 22 Poor 
5.  39 Vishva Raj 5/MC Habit of pica, Pallor of conjunctiva nail beds and tongue, Anorexia, lassitude, Ulceration of mouth, Palpitation, 08.01.2019 04.02.2019 28 Good 
6.  176 Deepa Suja 6/FC Habit of pica, Pallor of conjunctiva nail beds and tongue, Anorexia, lassitude, Ulceration of mouth. 28.01.2019 26.02.2019 30 Good 




8.  241 Mathumathi 5/FC Habit of pica, Pallor of conjunctiva nail beds, Anorexia, lassitude, dyspnoea on exertion, constipation. 04.02.2019 04.03.2019 29 Good 
9.  320 Boomika Devi 5/FC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, Ulceration of mouth, Hair fall, 
Palpitation 
11.02.2019 11.03.2019 29 Good 
10.  322 Hariharan 5/MC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, Ulceration of mouth, Constipation. 
 
 




11.  354 Poongothai 12/FC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, dyspnoea on exertion, palpitation, 
constipation 
13.02.2019 12.03.2019 28 Fair 
12.  367 Muthu Arun 8/MC Habit of pica, Pallor of conjunctiva nail beds and tongue, Anorexia, lassitude, Ulceration of mouth 14.02.2019 13.03.2019 28 Good 
13.  484 Jothi Rathinam 7/MC Habit of pica, Pallor of conjunctiva and  nail beds, Anorexia, lassitude, dyspnoea on exertion, palpitation 25.02.2019 26.03.2019 30 Good 
14.  549 Roshini 6/FC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, constipation, anal itching, fecus with 
worm. 
03.03.2019 02.04.2019 31 Good 
15.  678 Balaputhiyavan 6/MC 
Habit of pica, Pallor of conjunctiva and  nail beds, 
Anorexia, lassitude, emaciation, Ulceration of mouth, 
teeth grinding(Bruxism) 
16.03.2019 15.04.2019 31 Good 
16.  722 Thowfika 10/FC 
Habit of pica, Pallor of conjunctiva and nail beds, 
Anorexia, lassitude, dyspnoea on exertion, Ulceration of 
mouth. 
22.03.2019 22.04.2019 32 Good 
17.  723 Thowhetha 12/FC Habit of pica, Pallor of conjunctiva nail beds and tongue, Anorexia, lassitude, Palpitation, Emaciation. 22.03.2019 22.04.2019 32 Good 
18.  769 Simiyon 12/MC Habit of pica, Pallor of conjunctiva and nail beds, Anorexia, lassitude, constipation dyspnoea on exertion. 26.03.2019 22.04.2019 28 Poor 
19.  791 Muthukumar 12 /MC 
Habit of pica, Pallor of conjunctiva and nail beds, 
Anorexia, lassitude, palpitation. 27.03.2019 24.04.2019 29 Good 
20.  892 Syed Aiba 5/MC 
Habit of pica, Pallor of conjunctiva nail beds and tongue, 
Anorexia, lassitude, Ulceration of mouth.  Teeth bitting 
(Bruxism) 








Table no.17 HEAMATOLOGICAL INVESTIGATION RESULTS- IN PATENT 
Sl.No IP.No Name Age/Sex 












































































































1 1671 Mathavi 8 FC 8.5 2.5 25.5 102 34 32 H.M 10.9 3.2 32.7 102.1 34 32.3 N 
2 2452 Rajeshwari 10 FC 8.2 3.4 24.6 72.3 24.1 33 H.M 10.2 3.4 30.6 90 30.3 35 N 
3 3181 Samuvel 9 MC 9.1 2.9 27.3 94.1 31.3 33.3 H.M 10.9 3.6 32.7 91 31 36.1 N 
4 15 Senthamil Selvi 5 FC 8.1 3.2 24.3 75.9 25.3 31.2 H.M 10.1 3.6 30.3 84.1 28 33.3 N 
5 39 Vishva Raj 5 MC 8.3 3.1 24.9 80.3 27 32 H.M 10.6 3.5 31.8 91 30 34.2 N 
6 176 Deepa Suja 6 FC 7.4 2.46 22.2 90 30 33.3 H.M 9.8 3.2 29.4 91.8 31 33 H.M 
7 212 Rajesh 5 MC 7.6 2.53 25.8 90.5 30.7 33 H.M 9.9 3.3 29.7 91.2 30.7 33.3 N 
8 241 Mathumathi 5 FC 8.4 2.8 25.2 91.5 31.7 32.3 H.M 10.7 3.6 32.1 91.5 31.7 32.3 N 
9 320 Boomika Devi 5 FC 8.3 3.2 24.9 77.8 26 32.9 H.M 10.3 3.4 30.9 91 30.3 33.7 N 
10 322 Hariharan 5 MC 9.2 3.0 27.6 92 31 32.7 H.M 11.2 3.7 33.6 90 31 33.3 N 
11 354 Poongothai 12 FC 7.1 2.36 21.3 89.9 29 32.7 H.M 9.5 3.1 28.5 91.9 30 33.3 N 
12 367 Muthu Arun 8 MC 8.4 3.4 25.2 74.1 24.7 31.3 H.M 10.5 3.5 31.5 90 31 34 N 
13 484 Jothi Rathinam 7 MC 7.3 2.43 21.9 89.9 29.1 32.9 H.M 10.3 3.4 30.9 90.8 30 33.3 H.M 
14 549 Roshini 6 FC 7.6 2.53 22.8 89.9 29.1 32.9 H.M 10.2 3.4 30.6 90 30 34 N 
15 678 Balaputhiyavan 6 MC 8.9 2.9 26.7 92 30.6 33.6 H.M 11.3 3.8 33.9 89.3 31 35.3 N 
16 722 Thowfika 10 FC 9.1 3.0 27.3 89 31 33 H.M 10.8 3.6 32.4 90 31 33 N 
17 723 Thowhetha 12 FC 8.3 2.76 24.3 88 30 30.3 H.M 10.5 3.5 31.5 91 29.9 35.6 N 
18 791 Muthu Kumar 12 MC 8.1 3.7 24.3 65.6 22 33.3 H.M 11.7 3.9 35.1 92 30.3 32.3 N 
19 769 Simiyon 12 MC 7.4 2.46 22.2 90 30 33.3 H.M 10.1 3.3 30.3 91 29.3 33.3 N 
20 892 Syed Aiba 5 MC 8.1 3.4 24.3 71.4 23.8 33.3 H.M 11.2 3.7 33.6 90.8 30.2 33 N 
 
PCV - Packed Cell Volume   MCH - Mean Corpuscular   Hemoglobin   




INVESTIGATION RESULTS -  IN  PATIENTS 
S.No IP.No Age/ Sex 
Blood Urine Motion 













A S D A S D Ova Cyst OB Ova Cyst OB 
P L E ½ hr 
1  





1 1671 8 FC 7800 56 40 4 8 20 9800 62 35 3 2 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
2 2452 10 FC 7500 59 38 3 10 20 9500 61 37 2 4 6 Nil Nil NAD Nil Nil NAD P P P Nil Nil Nil 
3 3181 9 MC 8100 57 41 2 12 22 10300 61 37 2 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
4 15 5 FC 8800 59 40 1 6 12 10100 60 39 1 6 10 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
5 39 5 MC 9100 60 38 2 8 16 10100 60 37 3 2 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
6 176 6 FC 7900 57 37 6 10 20 9800 63 35 3 2 4 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
7 212 5 MC 7600 59 39 2 6 12 9300 61 37 2 2 4 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
8 241 5 FC 7300 60 35 5 9 18 9600 63 35 2 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
9 320 5 FC 8500 58 39 3 4 8 10000 60 37 3 3 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
10 322 5 MC 8900 57 41 2 2 10 10100 61 37 2 4 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
11 354 12 FC 7800 63 35 2 9 18 9800 60 38 2 2 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
12 367 8 MC 7100 57 38 5 8 18 9100 62 35 3 3 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
13 484 7 MC 8500 57 41 2 7 14 10100 65 34 1 2 4 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
14 549 6 FC 9800 55 40 5 9 18 10300 60 36 4 4 8 Nil Nil NAD Nil Nil NAD P P P Nil Nil Nil 
15 678 6 MC 9100 54 39 7 8 16 10100 62 34 4 4 10 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
16 722 10 FC 9700 53 44 3 6 12 10100 59 39 2 5 10 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
17 723 12 FC 8800 58 40 2 6 12 9100 61 38 1 2 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
18 791 12 MC 7500 51 45 6 10 20 9900 59 37 4 2 4 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
19 769 12 MC 7100 53 46 1 8 14 9100 57 39 4 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
20 892 5 MC 8500 55 44 1 6 18 10100 61 38 1 2 4 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
 
TC – Total Count      ESR – Erythrocyte  Sedimentation  Rate  A – Albumin  S-  Sugar   D – Deposit  
DC -  Differential Count      L – Lymphocytes   E-  Eosinophil   OB-  Occult Blood   
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HEAMATOLOGICAL INVESTIGATION RESULTS- OUT PATENT 
Sl.No IP.No Name Age/Sex 












































































































1 57300 Nirshath 5/MC 8.7 3.7 26.1 70.5 23.5 30.3 H.M 10.2 4.0 30.6 77 26 34 N 
2 57635 Amna 10/FC 9.8 3.2 29.4 91.8 30.6 32.3 H.M 11.2 3.6 33.6 93 31.1 32 N 
3 57988 Munda samy 8/MC 8.3 3.4 24.9 73.2 24.4 33.1 H.M 10.4 3.8 31.2 82.1 27.3 33.5 N 
4 63184 Siddharth 6 /MC 8.1 3.6 24.3 67.5 22.5 34.3 H.M 10.3 3.9 30.9 79.2 26.4 31 N 
5 63235 Yazhini devi 5/FC 9.1 3.1 27.3 88.0 29.3 33.4 H.M 11.5 3.5 34.5 98.5 32.8 36 N 
6 67899 Abrith 5/MC 7.7 2.6 23.1 88.8 29.6 30.1 H.M 9.2 3.0 27.6 92 30.6 32 H.M 
7 71314 Syed Thasleema 11/FC 9.4 2.8 28.2 100.7 33.5 32.3 H.M 10.8 3.4 32.4 95.2 31.7 33.5 N 
8 73296 Thayuba 5/FC 7.1 3.6 21.3 59.1 19.7 30.2 H.M 8.5 3.8 25.5 67.1 22.3 30.9 H.M 
9 73654 Esther Rani 12/FC 9.7 2.8 29.1 103.9 34.6 33.8 H.M 11.0 3.2 33 103.1 34.3 30 H.M 
10 81100 Muthumari 5/FC 9.2 3.8 27.6 72.6 24.2 32.3 H.M 10.9 4.0 32.7 82 27.2 35.1 N 
11 81733 Mahilini 12/FC 9.5 2.9 28.5 98.2 32.7 33.3 H.M 10.8 3.5 32.4 92.5 30.8 34 N 
12 81876 Sathya 5/FC 9.1 3.4 27.3 80.2 26.7 34.3 H.M 11.0 3.6 33 91.6 30.5 35.4 N 
13 96785 Ahamed Aathim 5/MC 8.5 3.5 25.5 72.8 24.2 31.9 H.M 10.0 3.8 30 79 26.3 35.4 N 
14 98194 Indhuja 5/FC 8.1 3.3 24.3 73.6 24.5 30.3 H.M 9.8 3.6 29.4 82 27.2 32.5 N 
15 102944 Anniya 5/FC 7.3 2.8 21.9 78.2 26 32.7 H.M 8.8 3.2 26.4 83 27.5 34 N 
16 103013 Sherin 6/FC 7.7 3.2 23.1 72.1 24 29.9 H.M 9.0 3.6 27 75 25 32.1 H.M 
17 105995 Sanju 8/MC 9.3 3.6 27.9 77.5 25.8 33.6 H.M 10.9 3.9 32.7 84 28 36 N 
18 105998 Latha 10/FC 8.3 3.0 24.9 83 27.6 30.4 H.M 10.1 3.4 30.3 89.1 29.7 32.2 H.M 
19 106711 Krishna Kumari 5/FC 8.9 3.4 26.7 78.5 26.1 31.8 H.M 10.4 3.6 31.2 86.6 29 33.5 N 
20 670 Mourthi 10/MC 8.1 2.8 24.3 86.7 28.9 34.2 H.M 10.2 3.1 30.6 99 33 36.3 N 
 
PCV - Packed  Cell Volume     MCH -  Mean  Corpuscular  Hemoglobin   




                                                          




Blood Urine Motion 
Before treatment After Treatment 
Before  
Treatment 








A S D A S D Ova Cyst OB Ova Cyst OB 










1 57300 5/MC 7500 61 34 5 7 15 8000 63 35 2 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
2 57635 10/FC 6500 64 32 4 5 10 7200 65 33 2 3 7 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
3 57988 8/MC 8100 58 40 2 3 7 9000 60 38 2 3 7 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
4 63184 6 /MC 7400 64 33 3 6 12 8000 64 34 2 2 4 Nil Nil NAD Nil Nil NAD P P P Nil Nil Nil 
5 63235 5/FC 8500 66 30 4 11 22 9200 63 35 2 5 10 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
6 67899 5/MC 7800 63 32 5 5 10 8500 62 35 3 2 5 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
7 71314 11/FC 8000 57 35 8 3 7 9100 60 36 4 3 7 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
8 73296 5/FC 7500 64 35 1 6 13 8600 65 34 1 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
9 73654 12/FC 8000 62 32 6 7 15 9200 64 33 3 5 10 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 







Blood Urine Motion 
Before treatment After Treatment 
Before  
Treatment 








A S D A S D Ova Cyst OB Ova Cyst OB 










11 81733 12 /FC 6700 60 38 2 4 8 8100 63 35 2 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
12 81876 5/FC 9500 62 35 3 5 11 10100 60 38 2 3 7 Nil Nil NAD Nil Nil NAD P P P Nil Nil Nil 
13 96785 5/MC 8400 63 32 5 6 13 9200 65 33 2 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
14 98194 5/FC 6400 65 31 4 7 13 9700 63 35 2 5 10 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
15 102944 5 /FC 6500 66 31 3 6 13 7800 61 37 2 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
16 103013 6/FC 7800 65 31 4 7 13 9100 63 34 3 3 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
17 105995 8/MC 6300 65 32 3 5 10 8200 60 38 2 3 6 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
18 105998 10/FC 6800 67 30 3 5 11 8500 62 34 4 4 8 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
19 106711 5/FC 8100 65 30 5 7 14 9000 60 36 4 6 12 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
20 670 10/MC 6900 65 30 5 4 8 7600 62 35 3 2 4 Nil Nil NAD Nil Nil NAD Nil Nil Nil Nil Nil Nil 
  
TC – Total Count      ESR – Erythrocyte  Sedimentation  Rate  A – Albumin  S-  Sugar   D – Deposit  




Table no.18  OUT PATIENTS CASE RECORD 
Sl. No. OP.NO Name Age/ Sex No. of days treated Remarks 
01.  57300 Nirshath 5/MC 29 Good 
02.  57635 Amna 10/FC 30 Good 
03.  57988 Munda samy 8/MC 29 Good 
04.  63184 Siddharth 6/MC 33 Good 
05.  63235 Yazhini devi 5/FC 33 Good 
06.  67899 Abrith 5/MC 32 Good 
07.  71314 Syed Thasleema 11/FC 40 Good 
08.  73296 Thayuba 5/FC 33 Fair 
09.  73654 Esther Rani 12/FC 32 Good 
10.  81100 Muthumari 5/FC 35 Fair 
11.  81733 Mahilini 12/FC 33 Good 
12.  81876 Sathya 5/FC 33 Good 
13.  96785 Ahamed Aathim 5/MC 35 Good 
14.  98194 Indhuja 5/FC 30 Good 
15.  102944 Anniya 5/FC 34 Good 
16.  103013 Sherin 6/FC 34 Poor 
17.  105995 Sanju 8/MC 32 Good 
18.  105998 Latha 10/FC 32 Good 
19.  106711 Krishna Kumari 5/FC 30 Poor 





Table no.19  Results after treatment 
S. NO Gradation No.of Cases Percentage 
1. Good 31 62.5 
2. Fair 5 25 







 Among the 40 patients selected 62.5% cases showed good response 






























 Mannun Veluppu Noi is a clinical entity described and its clinical features 
are loss of appetite, lassitude, and emaciation, pallor of the mucus membrane like 
conjunctiva, tongue and nails, dyspnoea on exertion, habit of pica. These features are 
identical with “ Iron deficiency Anaemia ” ( Hypochromic microcytic anaemia ) a 
Clinical entity described in modern literatures. The Clinical features of “ Mannun 
Veluppu  Noi ” have been furnished by some of the Siddha literatures like 
Balavagadam , yugi vadiya chinthamani, Agathiyar Gunavagadam etc,.. 
 
Incidence according to Age 
  In the present study,  occurrence of  “Mannun Veluppu Noi” was noticed 
among the age group of 5 to 12 years . This does not mean that the occurrence is more 
common in children belonging to age group of 5 to 12 years. One of the reason for 
this may be that the growth depends more amount of iron and nutrition than the 
normal adult. 
 
Incidence according to Sex 
 On the basis of the sex, the disease “Mannun Veluppu Noi” affects both male 
and female children more or less equally i.e 42% were male children and 58% were 
female children from the above data one cannot predict that the occurrence of  
Mannun Veluppu Noi on the basis of   sex. 
 
Incidence according to Religion 
 Regarding the distribution of this disease on the basis of religion of the 
patients, 65% were Hindus, 10% were Christians and 25% were Muslims. So on the 
basis of this data; one cannot predict the occurrence of the Mannun Veluppu Noi on 
the basis of religions. 
  
Incidence according to Thinai: 
  Similarly the distribution of patients on the basis of thinai, shows that 97.5% 
of patients belong to Marutham and 2.5% from kurinji. Since in Siddha literature 
Maruthanilam is considered as a disease free zone. However the changing life style, 
dietary habits from their ancestor and environment, poor socioeconomic status may be 
one of the reasons for this occurrence. Further the high temperature in Palayamkottai 
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and its surrounding areas may be responsible for increasing pitham and may result in 
increased occurrence of Mannun  Veluppu Noi. 
 
Incidence according to MukkuttraKaalam 
  Since the present study restricted to children below age of 12, all the patients 
belong to Vaatha kaalam only. So in the present study, it is inferred that in children 
Mannun Veluppu Noi is a Pitha disease occurring in Vaathakaalam. 
 
Incidence according to Socioeconomic Status 
  Regarding socioeconomic status of patients 65% were from poor families, 
35% were from middle class families. Hence this observation supports the view that 
occurrence and spreading of Mannun Veluppu Noi may be due to poor socioeconomic 
status of the patients. 
 
Diet 
  In the present study, it is noticed that 80% of patients had mixed food habits, 
consuming both vegetarian and non-vegetarian diets and 20% had vegetarian diet. 
 
Incidence according to cases from same family 
  The incidence of children has positive family history is 60% and negative 
family history is 40%. 
 
 Incidence according to Uyirthathukkal 
 Among the three vital forces, pitham is mainly affected in Mannun Veluppu 
Noi. Among the five types of pitham, especially Ranjaga pitham is  affected which 
causes discolouration of mucous membrane, other forms of Pitham, such as 
Anarpitham, Sathagam and Prasagam were affected in 40 cases, the derangement of 
pitham is followed by derangement of Kabam and Vatham 
 
Incidence according toEzhuudalkattukal 
  Among seven Udalkattukal, Saaram and Senneer were affected in 40 cases. 
 
Incidence according to Envagaithervugal 
  In this, the changes of naadi, sparisam, naa, niram, mozhi, vizhi, malam and 





 According to this study, vathapithanaadi were observed in 35% of cases, 
vathakabanadi in 15% of cases, pithavathanadi in 35% of cases, pithakabanadi in 
12.5% of cases, kabapithanaadi in 2.5%% of cases . 
 
SPARISAM 
 Palpable liver and spleen tenderness may be noted. Palpitation may be noted. 
The skin of the patient should also be noted. 
 
NAA 
          In all of the cases, the tongue was pallor in colour. 
 
NIRAM 
 Due to involvement of Pitham, the body was pallor in colour. Pallor  was 
observed in  all cases. 
 
MOZHI 
 Not affected in all cases. 
 
VIZHI 








  In Mannun veluppu Noi, due to increased pitham, the urine output was yellow 






Incidence according to Prognosis Assessment and Efficacy of Trial drug Siru 
Vilvathi Elagam 
  After conforming the diagnosis as Mannun Veluppu Noi, the patients were 
treated with “Siru Vilvathi Elagam” with a dose of 2.5gm twice a day after meals 
depending on the age and body weight of the patients. The observation of signs and 
symptoms were followed as long as the patients in the hospital as IN PATIENTS. The 
prognosis was clearly recorded. When symptoms disappeared the patients were 
discharged by examination of the blood and other systemic signs and symptoms once 
again. The selected trial Drug Siru Vilvathi Elagam has Stomachic, carminative and 
Nutritive action. Among 40 Patients who had been treated with Siru Vilvathi 
Elagam, shows good result in 31 cases, and fair result in 5 cases. This reveals that 
Siru Vilvathi Elagam had good effect in treating Mannun Veluppu Noi in 62.5% of 
patients and 25% of our trial, expressed moderate responses to Siru Vilvathi Elagam. 
 The aim of treatment is to increase the level of haemoglobin. As the trial drug 
has significant haematinic, stomachic, nutritive and tonic actions and it contains 
minerals such as iron, zinc, magnesium, calcium, potasium, manganese, phosphorus, 
copper, vitamins A, B complex, C, K the aim were attained. 
 During the treatment, iron rich diet was strictly advised. Along with the trial 
drug all the patients were advised to taken green leafy vegetables, fruits, meat, 







 Mannun Veluppu  Noi( Iron deficiency Anaemia) is a disease affecting both 
male and female children as per the Siddha and Modern system of Medicine. 
           To treat children with Mannun Veluppu Noi, a Siddha trial drug, “Siru 
Vilvathi Elagam" has been prepared. The collection, confirmation, and purification 
of all ingredients have been described. The method of preparation of “Siru Vilvathi 
Elagam” has also been described. 
          The Biochemical analysis of the trail drug Siru Vilvathi Elagam reveals the 
presence of Calcium, Sulphate, Ferrous iron, Unsaturated Compound and Amino 
Acid.  
          The pharmacological analysis of the trail drug Siru Vilvathi Elagam reveals the 
existence of   Haematinic and Hepatoprotective activity, and the results have been 
tabulated. Toxicity study reveals that there are no acute and sub-acute toxicity effects 
in the trail drug. 
          The microbiological analysis reveals  that  the drug Siru Vilvathi Elagam is 
sensitive to bacteria pseudomonas aeruginosa  and resistant to escherichia coli. 
           The trail drug, Siru Vilvathi Elagam has been used to treat 20 Inpatients and 
20 OUT PATIENTS of both sexes affected by Mannun Veluppu Noi in OP and IP 
ward of Post Graduate Department of  Kuzhanthai Maruthuvam, Government Siddha 
Medical College and Hospital.  Maximum occurance of this disease was observed in 
school going children(5 to 12years). 
 Before treatment, the signs and symptoms for Mannun Veluppu Noi are 
noticed and confirmed by clinical analysis. During treatment, the dose of 2.5 gm of 
Siru Vilvathi Elagam, twice a day after meals, has been given to children affected by 
Mannun Veluppu Noi depending on their age, body weight and severity of the 
disease. 
 Findings reveal about the impact of the disease in the body.  
             No adverse side effects were reported during or after the course of treatment. 
The drug selected for the study was found to be easily available drug, easy to 
administrate and also more effective against Mannun Veluppu Noi without any 
adverse side effects. 
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            The bio-chemical analysis and pharmacological study of the drug revealed its 
efficacy. From the studies, the drug Siru Vilvathi Elagam possesses significant 
Haematinic action. 
  By analysing and taking into consideration of all these results, it is inferred 
that the Siru Vilvathi Elagam has effective actions in treating the disease Mannun 
Veluppu Noi. 
 






  Siru vilvathi elagam has significant Haematinic and Hepatoprotective 
activity. 
 From the study it is clear that Mannun Veluppu Noi, is caused by 
derangement of pitham, followed by the derangement of vatham and kabam. 
 It has shown good result in controlling iron deficiency anaemia and it raises 
the hemoglobin level in anaemia patients when given regularly along with other 
healthy supplementary diets. 
 Both symptomatic relief and qualitative improvement were observed in the 
patients. It is also proved that it is effective treatment for Iron deficiency anaemia. No 
adverse effects were observed in the Siru Vilvathi Elagam treated patients. 
The drug is an herbal product, easily available, cost effective, easy to 
administrate, simple way of preparation, high efficacy, harmless to infants and 
children. 
 The dose of the drug used in the present study is to be used in paediatric 
practice to treat children with Mannun Veluppu Noi. 
            Ingredients of Siru Vilvathi Elagam have minerals such as iron, copper, zinc, 
calcium, potasium and vitamins A, B complex, C.   
 Because of these encouraging out coming results, the study may be undertaken 
with same medicine in a large number of cases and it may open new windows for the 
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ANNEXURE - II 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI 
POST GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
PRECLINICAL AND CLINICAL STUDY ON “MANNUN VELUPPU NOI”                           
- A PEDIATRIC DISORDER AND THE DRUG OF CHOICE IS                                
“SIRU VILVATHI ELAGAM”  
 
Form I - SCREENING & SELECTION PROFORMA 
S.I. No: ………….  OP/IP No: ……….  Name: ……………… 
Age: …………….  Gender: …………..Date of  Enrollment: …………. 
Date of Completion:…………. Informant:…………. Reliability:  …………… 
INCLUSION  CRETERIA:     YES      NO   
• Age 5-12 years. 
• Pallor of skin, conjunctiva, nail beds and tongue 




• Irritability   . 
• Worm infestation. 
• Anemia due to iron deficiency 
• Brittle nails. 
• Palpitation 
• Nail Biting 
EXCLUSION CRITERIA: 
• Age limit :More than 13 years 
• Patient with chronic infection 
• Bleeding disorder 
• Renal and liver diseases 
• Rheumatic fever 
• Nephrotic Syndrome 
• Malignancy of anytype 
(Thalassemia  major, aplastic anemia, Sicklecell 
anemia, Hemolytic anemia) 
Signature of Guide:          Signature of Principal Investigator: 
 




































GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI  
 
POST GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
 
PRECLINICAL  AND CLINICAL STUDY ON “MANNUN VELUPPU NOI”. A 
PEADIATRIC DISORDER AND THE DRUG OF CHOICE IS  
SIRU VILVATHI ELAGAM 
 
FORM IA – HISTORY PROFORMA ON ENROLLMENT 
 
Patient id: OP/IP NO. VISIT DATE (___/____/_____) 
NAME :  
AGE:  
Gender:   MALE           FEMALE  Date Of Birth :( ____/____/_____)   
Fathers/Mother/Guardian name :  
Fathers Occupation:  
Fathers Monthly income:  
Religion:  
Socioeconomic status:  









1. Complaints and duration  
 
 
2. Present illness  






History of past Illness 
History /Symptoms /Signs   Yes  No  if, Yes Details  
Any Similar Complaints      _____________ 
Bronchial Asthma       _____________ 
Dust Allergy        _____________ 
Hospitalization        _____________ 
Any Other         _____________ 
 
Family History       
Any hereditary familial Disease    Yes  No 
If yes, details………………………………………………………………………….. 
 
Immunization History  
Proper Immunization given   Yes  No …………………….. 
 
Food Habits:  
1. Veg   2. Non-Veg   3. Mixed  
 
General assessment                            Yes  No 
1. Pica 
2. Nail Biting 
3. Bowel Movements  
 
General Examination   Yes  No   
1. Pallor       
2. Jaundice        
3. Cyanosis         
4. Clubbing         
5. Pedal oedema        






















1. Pulse rate / mint 
2. Heart rate / mint 









Mid Arm Circumference 
 
CLINICAL EXAMINATION: 
             Normal            Affected 
 Cardio Vascular system:        
 Gastro intestinal system:        
 Musculo skeletal system:        
 Central nervous system:        
 Endocrine system:  
 





2. Colour: Normal    Reddish      Black    Pallor    








    
   
xviii 
 
EXAMINATION OF NAILS: 
1. Pallor:  Present              Absent               
2. Koilonychia: Present              Absent               
Nilam:  
 
            Kurinji  Mullai                Marutham        Neithal         Paalai 
KaalaIyalbu 
Kaarkalam  Koothirkaalam Munpanikaalam 
Pinpanikaalam Illavenikaalam Muthuvenrkaalam 
Yaakai 
 
Vatham  VathaPitham  VathaKabam 
 
Pitham   PithaVatham  PithaKabam 
 
Kabam   KabaVatham  KabaPitham 
UyirThathukkal 
Vatham 





























































































Niram     










































Niram  Normal   Affected 
Edai  Normal   Affected 
Nurai  Normal   Affected 
Manam Normal   Affected 








 Vatham  Pitham   Kabam 
 
ThonthaNadi 
 VathaPitham  VathaPitham              Pithavatham              Pithakabam 
    
                Kabapitham  
Sparism 
Diagnosis__________________________________ 
Admitted to trial: 1. Yes   2. No. 





Date:      
Signature of the Guide   Signature of Principal Investigator: 
 





   















GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
BRANCH IV – KUZHANTHAI MARUTHUVAM 
PALAYAMKOTTAI - 627 002. 










           
         
       












Bed. No. : 
 












PG-Kuzhanthai Maruthuvam Ward,  














Date of Admission: 
 
 
































Consanguinity    : 
 Ataxia     : 
 Blindness    : 
 CP     : 
 MR     : 
 Seizure    : 
 Movement disorder   : 
 Deafness    : 
Socio-Economic Status: 
Habits: 
 Bowel and micturition habit  : 
 Sleep     : 
 Enuresis    : 
 Thumb sucking   : 
 Nail biting    : 
 Pica     : 
Diet History: 
 Appetite    : 




 Medication    : 
 Infection (STARCH)   : 
 Irradiation    : 
 Toxaemia    : 
 Hemorrhage    :  
 Severe Anaemia   : 
 Eclampsia    : 
 H/o Decreased foetal Movements : 
 Maternal malnutrition   : 
 Maternal Diabetes Mellitus(DM) : 
 Maternal Hypertension  : 
Natal: 
 Breech presentation   : 
 Forceps / - C- Section   : 
 Home / Hospital   : 
 H/o prolonged labour   : 
Post Natal 
 Post-partum Haemorrhage  : 
 Sepsis     : 
Neonatal History: 
 Birth Weight    : 
 Term / Pre term baby   : 
 Congenital malformations  : 
 Birth Asphyxia – APGAR – Score : 
 Neonatal convulsions   : 
 Kernicterus    : 
 Diarrhoea    : 
Birth injury / Head injury / Activity of the child 
a) at birth   : 
b) after birth   : 




Resuscitation done or not  : 
(If done nature of resuscitation) 
Respiratory distress / cyanosis : 
Fever / altered sensorium  : 
Feeding after birth   : 










 Height    : 
Weight    : 
Head Circumference   : 
Chest Circumference   : 
Mid Arm Circumference  : 
1. Consciousness : 
2. Decubitus  : 
3. Anemia   : 
4. Jaundice   : 
5. Cyanosis   : 
6. Clubbing   : 
7. Pedal oedema  : 
8. Lymphadenopathy   : 
9. Nourishment  : 
10. Skin changes   : 
11. Edema   : 
12. JVP              : 
13. Pulse Rate   : 
14. Heart Rate   : 
xxv 
 
15. Respiratory Rate  : 
16. Temperature  : 
17. Blood Pressure  : 
18. Spine   : 
19. Skin    : 
Systemic Examination 
Cardio Vascular System : 
Respiratory System  : 
Gastro Intestinal System : 
Genito Urinary System : 
Nervous System  : 
 Consciousness: 
 Temper Tantrum:  Sociable- Irritable - Playful 
 Memory  : 
 Orientation  : 
 Speech   : 
 Intelligence (I.Q) : 
 Handedness  : 
Cranial Nerve Examination: 
Motor System: 
 Power  : 
 Tone  : 
 Reflex  : 
 Grip  : 
 Gait  : 
Sensory Examination: 
 Superficial Sensation: 
  Touch  : 
  Pain  : 
  Temperature : 
Deep Sensation: 
  Position sense : 
  Joint sense : 
  Vibration sense: 
xxvi 
 
 Cortical Sensation: 







Siddha Systems – Clinical Examination: 
Nilam 
Kurinchi  : 
Mullai   : 
Marutham  : 
Neithal   : 
Palai    : 
ParuvaKaalam 
Kaar   : 
Koothir  : 
Munpani  : 
Pinpani   : 
Elavenil  : 
Muthuvenil  : 
Uyirthathukal: 
Vatham 
Praanan  : 
Abaanan : 
Uthaanan  : 
Viyaanan  : 
Samaanan : 
Naagan  : 
Koorman : 
Kirugaran  : 
Devathathan : 




Analam  : 
Ranjagam  : 
Sathagam  : 
Alosagam  : 
Prasagam  : 
 
Kabam 
Avalambagam  : 
Kilethagam   : 
Pothagam   : 
Tharpagam   : 
Santhigam   : 
 
UdalKattugal 
Saaram    : 
Senneer   : 
Oon     : 
Kozhuppu   : 
Enbu     : 
Moolai    : 
Sukkilam/Suronitham  : 
 
EnvagaiThervugal 
Naa   : 
Niram               : 
Mozhi    : 
Vizhi    : 
Sparisam   : 
Nadi    : 
Malam    : 





Niram    : 
Manam   : 
Nurai    : 
Edai    : 





Nirami   : 
Nurai    : 
Elagal   : 
Erugal   : 
Lab Investigations 
1. Blood 
TC  : 
DC : 
Hb  : 
ESR  : 
2. Urine 
Albumin  : 
Sugar   : 
Deposits  : 
3. Motion 
Ova   : 
Cyst  : 
Occult blood  : 
4. Special investigations 
 PCV  : 
 MCV  : 
 MCH  : 
 MCHC : 
 Peripheral smear : 
xxix 
 
DIFFERNTIAL DIAGNOSIS  : 
PROGNOSIS    : 
MARUTHUVAMURAI   : 
ADVICE     : 






   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
PALAYAMKOTTAI  
 
POST GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
 
PRECLINICAL AND CLINICAL STUDY ON “MANNUN VELUPPU NOI”-A 
PEDIATRIC  
DISORDER AND THE DRUG OF CHOICE IS SIRU VILVATHI ELAGAM 
FORM - II&IIA  
CLINICAL ASSESMENT ON ENROLLMENT DURING AND AFTER TRIAL 
S.I.No: ………….        OP/IP No: …………  Name: ……………… 
Age: …………….  Gender:  …………..   Date of Enrollment: ………… 
Date of Completion :………….   Informant: …………. Reliability:  …………… 
SIDDHA SYSTEM OF EXAMINATION 
 
 I.ENVAGAI THERVU: [EIGHT-FOLD EXAMINATION] 
 



















7.MALAM: [BOWEL HABITS / STOOLS] 
 MALAM 1stDay 09thDay 18
th














































8. MOOTHIRAM [URINE EXAMINATION]: 
NEERKURI 1stDay 09thDay 18
th
 Day 27th Day 
Niram White/ White/ White/ White/ 
[Colour] Yellowish/ Yellowish/ Yellowish/ Yellowish/ 
 Straw Straw Straw Straw 
 coloured/ Coloured/ coloured/ coloured/ 
 Crystal Crystal Crystal Crystal 











Nurai [Froth] Nil/Reduced/ 
Increased 












/ Reduced   
Normal/ Increased/ 
Reduced 
Enjal [Deposits] Present/ 
Absent 



















II.THEGI: [TYPE OF BODY CONSTITUTION] 
 
                                                                                                                                         
III.NILAM: [LAND WHERE PATIENT LIVED MOST] 
    Kurinji                  Mullai         Marutham       Neithal             Palai  
(Hillyterrain)          (Forestrange)             (Plains)               (Coastalbelt)     (Aridregions) 
IV.KAALAM: 
Kaarkalam  -   Pinpanikalam   - 
Koothirkalam  -   Ilavenil  - 
Munpanikalam -   Muthuvenil  -  






 Day 27th Day 
Praanan     
Abaanan     
Viyaanan     
Udhaanan     
Samanan     
Naagan(Higher intellectual 
function) 
    
Koorman(airway of yawning)     
Kirukaran(Air of 
salivation/nasal  secrection) 
    
Devathathan (Air of laziness)     
Dhananjeyan(this air that acts 
on death) 
    
NEIKURI 1stDay 09thDay 18
th
 Day 27th Day 
Serpentine fashion     
Annular/Ringed  fashion     
Pearl beaded fashion     









 Day 27th Day 
Analpitham (Gastric juice)     
Ranjagam(Haemoglobin)     
Praasagam (Bile)     
Saathagam(Life energy)     








 Day 27th Day 
Avalambagam (Serum)     
Kilaethagam (saliva)     
Pothagam (lymph)     
Tharpagam(cerebrospinal fluid)     
Santhigam(synovialfluid)     
 





 Day 27thDay 
Saaram [Chyme]     
Senneer [Blood]     
Oon [Muscle]     
Kozhuppu [Fat]     
Enbu [Bones]     
Moolai [Bonemarrow]     
Sronitham[Genital  discharges]     
 
1. SYSTEMIC EXAMINATION: 
          SYSTEM 1stDay 09thDay 18
th
 Day 27th 
1)Gastrointestinal  System     
2) Respiratory System     
3)Cardiovascular  System     
4)Central Nervous System     





 Height    : 
Weight    : 
Head Circumference   : 
Chest Circumference   : 
Mid Arm Circumference  : 















Temperature (F0)         
Pulse rate (per min)         
Heart rate (per min)         
Respiratory rate(per 
min) 
        
Blood pressure 
(mm/Hg) 
        
Anaemia         
Jaundice         
Cyanosis         
Lymph adenopathy         
Pedal edema         
Clubbing         
Jugular vein 
pulsation 
        
xxxv 
 
3. CLINICAL SYMPTOMS: 




   
 
H/o Pica 
    
Anorexia 
    
Fatigue 
    
Constipation 
    
Loss of appetite 
    
Lassitude 
    
palpitation 
    
Worm Infestation 







Signature of the Investigator: 
 
Signature of the Guide: 
 




GOVERNMENT SIDDHA MEDICAL 
COLLEGE&HOSPITALPALAYAMKOTTAI 
POST GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
PRECLINICAL AND CLINICAL STUDY ON “MANNUN VELUPPU NOI”-A 
PEDIATRIC  
DISORDER AND THE DRUG OF CHOICE IS SIRU VILVATHI ELAGAM 
 
S.I.No: ………….  OP/IP No: …………  Name: ……………… 
Age: …………….  Gender: …………..Date of Enrollment: …………. 
Date of Completion:…………. Informant:…………. Reliability:  …………… 
 
FORM III – LABORATORY INVESTIGATION 
 






Hb (gms%)    11.5- 14.5   
RBC (million/cu.mm) 4-5.5   
ESR(mm) ½ hr. 0-4   
1hr. 0-13   
WBC (million/cu.mm) 5000-14500   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 28-48   
Monocytes 3-6   
Eosinophils 0-3   
Basophils 0-1   
PCV(%) 30-43   
MCV (femoliters) 86-96   
MCH (Pg) 27-33   
MCHC (g/dL RBC) 30-35   






Urine Investigation Before TMT  
Date : 
After TMT  
Date : 
Albumin   
Sugar   
Deposits   
 
 
Stools Investigation Before TMT  
Date : 
After TMT  
Date : 
OVA   
Cyst   
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GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI 




An open clinical study to evaluate the clinical efficacy of Siddha sasthric 
formulation “SIRU VILVATHI ELAGAM” for the management “MANNUN 
VELUPPU NOI” 
CERTIFICATE BY INVESTIGATOR 
  I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent. 
Date ……………….      Signature………….. 
place ……………….      Name ……………… 
 CONSENT OF INFORMANT  
I have been informed to my satisfaction, by the attending physician, the 
Purpose of the clinical trial, and the nature of drug treatment and follow-up 
Including the laboratory investigations to be performed to monitor and safeguard my 
Son / Daughter body functions. 
I am aware of my right to put out of the trial at any time during the course of 
the trial without having to give the reasons for doing so. 
I am, exercising my free power of choice; hereby give my consent to be 
 included as a subject in the clinical trial of “SIRU VILVATHI ELAGAM” for the 
treatment of “MANNUN VELUPPU NOI” 
Informant Signature:………. 
Date:        Informant Name: …………. 
Place:        Patient Name:………………. 
Signature of Witness     Relationship:………………… 
xl 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE&HOSPITAL 
PALAYAMKOTTAI                          
POST GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
PRECLINICAL AND CLINICAL STUDY ON “MANNUN VELUPPU NOI”-A 
PEDIATRIC  
DISORDER AND THE DRUG OF CHOICE IS SIRU VILVATHI ELAGAM 
 
S.I.No: ………….        OP/IP No: …………  Name: ……………… 
Age: …………….  Gender:  …………..   Date of Enrollment: …………. 
Date of Completion :…………. Informant: …………. Reliability :  …………… 
 
FORM IVB – WITHDRAWAL 
 
Date of Trial commencement  : 
Date of withdrawal from trial  : 
Reason (s) for withdrawal   : Yes /No 
Long absence at reporting   : Yes /No 
Irregular treatment    : Yes /No 
Shift of locality    : Yes /No 
Complication adverse reactions if any: Yes /No 
Exacerbation of symptoms   : Yes /No 













FORM IV-C – PATIENT INFORMATION SHEET 
Name of the principal investigator: 
……………………………………………………. 
Name of the institution  :  GOVERNMENT SIDDHA MEDICAL  
         COLLEGE&HOSPITAL, 
 Palayamkottai 
Information sheet for patients participating in the open clinical, trial  
 
1, _____________________________________ Studying as PG Scholar at 
GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL, 
PALAYAMKOTTAI  is doing a trail on the study “MANNUN VELUPPU NOI” 
(IRON DEFICIENCY ANEMIA). It is a most common disease in children. In this 
regard, I am in a need to ask you few questions. I will maintain confidentially of your 
comments and data obtained. There will be no risk of disclosing your identity and no 
physical, psychological or professional risk is involved by taking part in this study. 
Taking part in this study is voluntary. No compensation will be paid to you for taking 
part in this study.  
You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions.  
If you agree your child to be a participate in this study, he/she will be included 
in the study primarily by signing the concern form and then you will be given the 
internal medicine  





Signature of Guide:              Signature of Principal Investigator: 
 
 




GOVERNMENT SIDDHA MEDICAL COLLEGE&HOSPITAL 
PALAYAMKOTTAI 
POST GRADUATE DEPARTMENT OF KUZHANTHAI 
MARUTHUVAM 
 
PRECLINICAL AND CLINICAL STUDY ON “MANNUN VELUPPU 
NOI”-A PEDIATRIC DISORDER AND THE DRUG OF CHOICE IS  
SIRU VILVATHI ELAGAM 
FORM IVD- DIETARY ADVICE FORM 
S.I.No: ………….    OP/IP No: …………  Name: ……………… 
Age: ……………. Gender:  …………..   Date of Enrollment: …… 
Date of Completion :……… Informant: …………. Reliability :  …………… 
 
The following diet to be taken: The following food should be avoided 
 
• Drink adequate water 
• Green leafy vegetables 





• Red meat 




• Brown Rice  
• Beef liver 
• Eggs 
• Avoid bitter and sour taste 
foods  
• Milk and milk products 
• Agathi keerai 







Signature of the Investigator: 
 
Signature of the Guide: 
              Signature of the HOD 
xliii 
 
Form – IVE 
NATIONAL PHARMACOVIGILANCE PROGRAMME FOR 
SIDDHA DRUGS 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
 
Please Note: i. All Consumers/Patients and reporters information will remain  
          Confidential.  
  ii. It is requested to report all suspected reactions to the concerned,  
                            even if it does not have complete data, as soon as possible.  
 
Peripheral centrecode :      State : 





Father Name  
 









Date of Birth/Age 




2. Description of the suspected adverse reactions please complete boxes below 





Description of reaction  
 
 




3. List of all medicines/Formulations including drugs of other systems used by 









Diagnosis for which 










     
 
4. Brief details of the Siddha Medicine which seems to be toxic: 
1) 
Details Drug  
a) Name of the Medicine   
b) Manufacturing unit 
and batch no. and date 
 
c) Expiry date  
d) Purchased and 
obtained from 
 
e) Composition of the 
formulation / part of 




2) Dietary restrictions if any 
3) Whether the drug is consumed under institutionally qualified medical 
     Supervision or used as self-medication 
4) Any other relevant information  
xlv 
 
5. Treatment provided for adverse reaction: 
 
 
6. The result of the adverse reaction /side effect / untoward effects (Please 




Unknown Fatal If fatal 
Date of death: 
Severe Yes /No Reaction abated after drug stopped or dose reduced 
 




Was the patient admitted to hospital? If 
yes, give name and address of hospital  
 
 




8. Whether the patient is suffering with any chronic disorders? 
 
Hepatic    Renal  Cardiac Diabetes 
 Malnutrition  
 
Any Others  
 
9. H/O previous allergies /Drug reactions: 
 





Type (please tick):Nurse/Doctor/Pharmacist/Health 


















Signature of the reporter      Date : 
 
 




Government Siddha Medical 
College &Hospital, 
Palayamkottai, Post Graduate 





 The Co-ordinator, 
Dept. of Pharmacovigilance  





This Filled- in ADR report may be send within one month of observation / 



















Signature of Investigator: 
 









Who can report?  
 Any health care professionals like Siddha Doctors 
/Nurses /Siddha Pharmacists /Patients Etc.,   
What to report? 
 All reactions, Drug interactions 
Confidentiality  
 The patient’s identify will be held in strict confidence 
and protected to the fullest extent 
xlviii 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
BRANCH IV – KUZHANTHAI MARUTHUVAM 
PALAYAMKOTTAI - 627 002. 
Form IVF -ADMISSION – DISCHARGE SHEET 
Name of the medical unit  :    Nationality  : 
I.P.No     :     Religion  : 
Bed No    :    Informant  : 
Name     :    Date of Admission : 
Age/Sex    :    Date of Discharge : 
Occupation (parents)   :    No. of days treated  : 
Income (parents)   :    Diagnosis  : 
S.No 
 





1 Pallor of  conjunctiva, 
Nail beds and Tongue 
  
2 Habit of Pica   
3 Lassitude   
4 Loss of appetite   
5 Constipation   
6 Fatigue   
7 Dyspnoea on Exertion   
8 Palpitation   
9        Ulceration of mouth   





Date:            
           




GOVERNMENT SIDDHA MEDICAL COLLEGE&HOSPITAL 
PALAYAMKOTTAI 
 
POST GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
 
PRECLINICAL AND CLINICAL STUDY ON “MANNUN VELUPPU NOI”-A 
PEDIATRIC DISORDER AND THE DRUG OF CHOICE IS SIRU VILVATHI 
ELAGAM 
FORM V-DRUG COMPLIANCE  
 
S.I.No: ………….  OP/IP No: ………… Name: ……………… 
Age: …………….  Gender: …………..  Date of Enrollment: …………. 
Date of Completion :…………. Informant:………..   Reliability :  …………… 
 
NAME OF THE DRUG   : SIRU VILVATHI ELAGAM 
FORM OF THE DRUG    : ELAGAM 
ADMINISTRATION &ADJUVANT : PER ORAL  
DOSE & DURATION    : 2.5gm DAILY FOR 27 DAYS 
NO OF DRUG PACKS GIVEN   : ________________ 
NO OF DRUG PACKS RETURNED : ________________ 
DAY 
DATE OF DRUG 
INTAKE 
MORNING EVENING 
DAY 1    
DAY 2    
DAY 3    
DAY 4    
DAY 5    
DAY 6    
DAY 7    
DAY 8    
l 
 
DAY 9    
DAY 10    
DAY 11    
DAY 12    
DAY 13    
DAY14    
DAY 15    
DAY 16    
DAY 17    
DAY 18    
DAY 19    
DAY 20    
DAY 21    
DAY 22    
DAY 23    
DAY 24    
DAY 25    
DAY 26    
DAY 27    
 
 




Signature of the Guide:   Signature of HOD:       
 
